vancomycin has been researched along with oxacillin in 293 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 58 (19.80) | 18.7374 |
| 1990's | 24 (8.19) | 18.2507 |
| 2000's | 100 (34.13) | 29.6817 |
| 2010's | 87 (29.69) | 24.3611 |
| 2020's | 24 (8.19) | 2.80 |
| Authors | Studies |
|---|---|
| Barrett, JF; Demers, JP; Foleno, BD; Fraga-Spano, SA; Goldschmidt, RM; Hlasta, DJ; Johnson, SG; Kanojia, RM; Loeloff, MJ; Macielag, MJ; Russell, RK; Sui, Z; Webb, GC; Weidner-Wells, MA; Werblood, H | 1 |
| Barrett, JF; Demers, JP; Foleno, BD; Fraga-Spano, SA; Guan, J; Hilliard, JJ; Hlasta, DJ; Macielag, MJ; Ohemeng, KA; Sheppard, CM; Sui, Z; Webb, GC; Weidner-Wells, MA; Werblood, H | 1 |
| Barrett, JF; Foleno, BD; Fraga-Spano, S; Hlasta, DJ; Macielag, MJ; Nguyen, VN; Ohemeng, KA; Webb, GC; Weidner-Wells, MA; Werblood, HM | 1 |
| Lee, GH; Li, SY; Lin, CH; Shen, CC; Sun, CM; Syu, WJ | 1 |
| Eldridge, GR; Garo, E; Goering, MG; Hough, GW; Hu, JF; O'Neil-Johnson, M | 1 |
| Apiratikul, N; Aroonrerk, N; Suksamrarn, A; Yingyongnarongkul, BE | 1 |
| Clark, NC; Donlan, RM; Dumas, N; Jensen, B; Kohlerschmidt, D; Limberger, RJ; McDougal, LK; Musser, KA; Patel, JB; Shin, DH; Thompson, J; Weigel, LM; Zhu, W | 1 |
| Abbanat, D; Bush, K; Flamm, RK; Foleno, BD; Goldschmidt, RM; Macielag, MJ; Paget, SD; Webb, GC; Wira, E | 1 |
| Badiou, C; Benito, Y; Bes, M; Boisset, S; Dumitrescu, O; Etienne, J; Lina, G; Reverdy, ME; Vandenesch, F | 1 |
| Bradbury, BJ; Buechter, DD; Cheng, J; Deshpande, M; Mushtaq, G; Podos, SD; Pucci, MJ; Thanassi, JA; Thoma, CL; Vigliotti, GA | 1 |
| Baltch, AL; Bopp, LH; Michelsen, PB; Ritz, WJ; Smith, RP | 1 |
| Cho, JM; Chong, Y; Kim, CK; Kim, CM; Kim, JM; Lee, K; Ro, S; Yong, D; Yum, JH | 1 |
| Fein, M; Kong, L; Oluola, O; Weisman, LE | 1 |
| Kwon, DH; Lu, CD | 1 |
| Cheung, A; Götz, F; Herbert, S; Meehl, M | 1 |
| Jansen, WT; Milatovic, D; Verel, A; Verhoef, J | 1 |
| Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P | 1 |
| Berger-Bächi, B; Brassinga, AK; McCallum, N; Sifri, CD | 1 |
| Cui, L; Hiramatsu, K; Matsuo, M; Neoh, HM; Takeuchi, F; Yuzawa, H | 1 |
| Chung, M; Sieradzki, K; Tomasz, A | 1 |
| Clark, NC; Hageman, J; McDonald, LC; McDougal, LK; Patel, JB; Zhu, W | 1 |
| Archer, GL; Fox, PM; Noto, MJ | 1 |
| Baltch, AL; Bopp, LH; Michelsen, P; Ritz, WJ; Smith, RP | 1 |
| Higashide, M; Ichimura, S; Kumano, M; Kuroda, M; Ohkawa, S; Ohta, T; Omura, CT | 1 |
| Brown-Driver, V; Finn, J; Haselbeck, RJ; Hilgers, MT; Kedar, GC; Reyes, DR; Shaw, KJ; Stidham, MA | 1 |
| Castanheira, M; Deshpande, LM; DiPersio, J; Jones, RN; Mendes, RE; Saubolle, MA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Antignac, A; Chung, M; Kim, C; Tomasz, A | 1 |
| Jayaswal, RK; Ledala, N; Pearson, S; Sitthisak, S; Steidl, R; Stephenson, RE; Wilkinson, BJ | 1 |
| Amsler, KM; Bush, K; Davies, TA; Jacobs, MR; Shang, W | 1 |
| Biek, D; Ge, Y; Sahm, DF; Talbot, GH | 1 |
| Camargo, IL; Cui, L; Hiramatsu, K; Neoh, HM | 1 |
| Brown-Driver, V; Finn, J; Pillar, CM; Poppe, S; Schaadt, R; Shaw, KJ; Shinabarger, D; Zurenko, G | 1 |
| Cui, L; Hiramatsu, K; Neoh, HM; Shoji, M | 1 |
| Denis, O; Nguyen, HA; Struelens, MJ; Theunis, A; Tulkens, PM; Van Bambeke, F; Vergison, A | 1 |
| Berger-Bächi, B; Bischoff, M; Goerke, C; Homerova, D; Kormanec, J; Meier, S; Schulthess, B; Wolz, C | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Cui, L; Hiramatsu, K; Katayama, Y; Murakami-Kuroda, H | 1 |
| Brunner, LS; Haas, W; Lee, JC; Morris, TW; Pillar, CM; Zurenko, GE | 1 |
| Schaadt, R; Shinabarger, D; Sweeney, D; Zurenko, G | 1 |
| Chen, H; Chen, M; Liu, Y; Ma, Y; Nichols, WW; Sun, W; Wang, H; Zhang, J; Zhao, C | 1 |
| Jang, KP; Kang, H; Kim, CH; Kim, H; Lee, E; Na, SW | 1 |
| Han, S; Hwang, JK; Lee, K; Rukayadi, Y; Yong, D | 1 |
| Arhin, FF; Draghi, DC; Moeck, G; Parr, TR; Pillar, CM; Sahm, DF | 1 |
| Amsler, CD; Amsler, MO; Baker, BJ; Kyle, DE; Ma, WS; Maiese, WM; McClintock, JB; Mutka, T; Perman, JA; Singh, MP; Vesley, B; Zaworotko, MJ | 1 |
| Kadlec, K; Schwarz, S | 1 |
| Chen, HC; King, CH; Lai, JF; Lauderdale, TL; Shiau, YR | 1 |
| Bavari, S; Bowlin, TL; Houseweart, C; Moir, DT; Opperman, TJ; Panchal, RG; Peet, NP; Williams, JD | 1 |
| Jang, DS; Jang, KP; Kang, H; Kim, CH; Kim, H; Lee, E; Na, SW | 1 |
| Al-Qawasmeh, RA; Huesca, M; Lee, Y; Nedunuri, V; Peralta, R; Wright, J; Young, A | 1 |
| Chen, FJ; Huang, IW; Lauderdale, TL; Lee, CH; Wang, MC | 1 |
| Barrow, EW; Barrow, WW; Berlin, KD; Bourne, CR; Bourne, PC; Bunce, RA | 1 |
| Chan, JL; Cheung, GY; Joo, HS; Otto, M | 1 |
| Camargo, IL; Cui, L; Fukuda, M; Hiramatsu, K; Hishinuma, T; Isii, T; Neoh, HM; Ochiai, T; Shoji, M; Watanabe, Y | 1 |
| Baek, SY; Chae, SE; Cho, YL; Jeong, JW; Jung, SJ; Kim, YZ; Kwak, JH; Lee, HH; Lee, HS; Park, TK; Woo, SH | 1 |
| Brennan, OM; Coleman, DC; Ehricht, R; Monecke, S; Schwarz, S; Shore, AC; Slickers, P | 1 |
| Bradbury, BJ; Deshpande, M; Hashimoto, A; Kim, HY; Lucien, E; Nelson, DM; Pais, GC; Podos, SD; Pucci, MJ; Thanassi, JA; Wang, Q; Wiles, JA | 1 |
| Antypenko, OM; Berest, GG; Katsev, AM; Kovalenko, SI; Nosulenko, IS; Shandrovskaya, OS; Voskoboynik, OY | 1 |
| Kaul, M; Kelley, C; LaVoie, EJ; Lu, S; Parhi, A; Pilch, DS | 2 |
| Kaul, M; Kelley, C; LaVoie, EJ; Parhi, A; Pilch, DS | 1 |
| Kaul, M; Kelley, C; LaVoie, EJ; Parhi, A; Pilch, DS; Zhang, Y | 1 |
| Giurleo, D; Kaul, M; LaVoie, EJ; Parhi, A; Pilch, DS; Zhang, Y | 1 |
| Mlostoń, G; Pieczonka, AM; Sadowska, B; Stączek, P; Strzelczyk, A | 1 |
| Jadhav, JR; Jung, SJ; Kim, HS; Kwak, JH | 1 |
| Kaul, M; LaVoie, EJ; Parhi, AK; Pilch, DS; Pradhan, P; Saionz, KW; Trivedi, K; Zhang, Y | 1 |
| Gan, M; Guan, Y; Hu, X; Shang, X; Tan, Y; Wang, Y; Wu, C; Xiao, C; Yang, Z; You, X; Zhou, H | 1 |
| Antunes, NT; Boudreau, MA; Chang, M; Ding, D; Lastochkin, E; Leemans, E; Lichtenwalter, K; Mobashery, S; O'Daniel, PI; Peng, Z; Pi, H; Schroeder, VA; Song, W; Spink, E; Suckow, MA; Testero, SA; Vakulenko, S; Wolter, WR | 1 |
| Athanassopoulos, CM; Dinos, GP; Garnelis, T; Kalpaxis, DL; Kostopoulou, ON; Kournoutou, GG; Leotsinidis, M; Magoulas, GE; Papaioannou, D | 1 |
| Bentabed-Ababsa, G; Chevallier, F; Duval, RE; Fontanay, S; Halauko, YS; Ivashkevich, OA; Matulis, VE; Mongin, F; Nagaradja, E; Philippot, S; Roisnel, T; Scalabrini, M | 1 |
| Estévez-Braun, A; Feresin, GE; Machín, F; Martín, P; Peña, R; Tapia, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bell, LJ; Bewley, CA; Liu, H; Lohith, K; O'Connor, RD; Pulliam, TH; Rosario, M | 1 |
| Brozovic, A; Dowson, CG; Gazvoda, M; Košmrlj, J; Lloyd, A; Osmak, M; Proud, C; Roper, DI; Vajs, J | 1 |
| Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
| Abulkhair, HS; Cooper, B; Eid, I; Elsebaei, MM; Hagras, M; Hegazy, YA; Mayhoub, AS; Mohammad, H; Peters, CE; Pogliano, J; Pogliano, K; Seleem, MN | 1 |
| Barua, N; Blanchard, N; Chan, PK; Chan, ST; Hanquet, G; Ip, M; Lin, L; Ma, C; Qiu, Y; Shek, TL; Tsang, TF; Yang, X; Zhang, Y; Zuo, Z | 1 |
| Gao, Y; Li, C; Liu, C; Ren, B; Shim, SH; Xia, X; Yin, X; Yu, R; Zhang, L; Zhao, P; Zhu, C; Zhu, J | 1 |
| Bisio, A; Bürgi, T; Calzia, D; Danton, O; De Riccardis, F; De Tommasi, N; Giacomini, M; Hamburger, M; Panfoli, I; Pedrelli, F; Poli, G; Reinhardt, JK; Schito, AM; Schito, GC; Tuccinardi, T | 1 |
| Kandi, SK; Kumar, P; Mukhopadhyay, K; Rawat, DS | 1 |
| Brel, O; Dusfour, I; Eparvier, V; Lechat, C; Levasseur, M; Litaudon, M; Pellissier, L; Stien, D; Touré, S; Van-Elslande, E; Wolfender, JL | 1 |
| Amada, H; Endo, M; Hitaka, K; Kamitani, M; Masuko, A; Mihara, Y; Mima, M; Ohtake, N; Sugiyama, H; Takata, I; Takeuchi, T; Tamura, Y; Tanaka-Yamamoto, N; Ushiyama, F; Wada, R | 1 |
| Alexandrova, LA; Avdanina, DA; Boykova, YV; Efimenko, TA; Efremenkova, OV; Glukhova, AA; Jasko, MV; Karpenko, IL; Kochetkov, SN; Kolonitskaya, DP; Kost, NV; Negrya, SD; Nuraeva, GK; Shevchenko, OV; Solodinin, AP; Solyev, PN; Volkov, IA; Zhgun, AA | 1 |
| Alam, MA; Basnakian, AG; Frangie, MM; Gilmore, DF; Hansa, RK; Khan, MMK; Savenka, AV; Shelton, RS; Shuttleworth, SL; Smeltzer, MS | 1 |
| Agostinho, ÍRC; Araújo, AR; Campos, MAS; de Alcântara Oliveira, FA; de Carvalho Sousa, B; de Oliveira Castelo Branco, RR; Dos Santos Soares, MJ; Gonzalez, AGM; Lopes, AP; Pinheiro, REE; Rocha, JA | 1 |
| Majik, MS; Rodrigues, L; Tilve, SG | 1 |
| Abugazleh, MK; Alam, MA; Ali, H; Gilmore, D; Raj Kc, H; Roy, S; Saleh, I | 1 |
| Dayal, N; Onyedibe, KI; Sintim, HO | 1 |
| Bora, A; Deka, B; Devi, MV; Dihingia, A; Pahari, P; Sarma, S; Sen, T; Singh, AK; Suri, M | 1 |
| Abrutyn, E; Lane, TW | 1 |
| Donta, ST; Massanari, RM | 1 |
| Verbist, L; Verhaegen, J | 1 |
| Bayer, AS; Norman, DC; Yeaman, MR | 1 |
| Lenz, W; Machka, K; Milatovic, D; Voss, A | 1 |
| Auckenthaler, R; Chuard, C; Herrmann, M; Lew, DP; Lucet, JC; Rohner, P; Waldvogel, FA | 1 |
| Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR; Sinn, LM | 1 |
| Benes, CA; Greenberg, RN | 1 |
| Messer, M; Nguyen, H; Rolston, KV | 1 |
| Amsterdam, D; Beam, TR; Gorzynski, EA; Rotstein, C | 1 |
| Low, DE; McGeer, A; Poon, R | 1 |
| Brauner, E; Davey, P; Gorbach, S | 1 |
| Cheng, DL; Chiu, ZH; Fung, CP; Liu, CY; Wang, FD; Wang, LS | 1 |
| Traub, WH | 1 |
| Ehni, WF; Reller, LB | 1 |
| Klastersky, J; Van der Auwera, P | 1 |
| Guay, D; Klicker, R; Pence, T; Peterson, P | 1 |
| Knapp, CC; Washington, JA | 1 |
| Verbist, L | 1 |
| Gilligan, PH; Hodinka, RL; Jack-Wait, K; Walden, TP; Wannamaker, N | 1 |
| Baltch, AL; Bassey, C; Fanciullo, G; Smith, RP | 1 |
| Jackson, CG | 1 |
| Baker, CB; Pelletier, LL | 1 |
| Hsiao, KM; Hsiao, RL; Lin, TY; Ni, SL; Wang, AM | 1 |
| Klastersky, J; Van der Auwera, P; Van Laethem, Y | 1 |
| Bourgault, AM; Bryan, L; Harding, GJ; Henry, DA; Hoban, DJ; Horsman, GB; Marrie, T; Smith, JA; Turgeon, P | 1 |
| Klastersky, J; Legrand, JC; Meunier-Carpentier, F; Thys, JP; Van der Auwera, P | 1 |
| Ho, JL; Klempner, MS | 1 |
| Watanakunakorn, C | 1 |
| Tomasz, A | 1 |
| Benner, EJ; Kayser, FH | 1 |
| Waddell, AD; Walsh, WT; Wisseman, CL | 1 |
| Barza, M; Baum, J; Ernst, C; Weinstein, L | 1 |
| Hubmann, R | 1 |
| Hoppes, WL; Lerner, PI | 1 |
| Pulverer, G | 1 |
| Gombosuren, T; Jezek, Z; Mingir, G; Rusinko, M | 1 |
| Fomina, IP; Kuznetsova, SM; Speranskaia, ON | 1 |
| Bottone, EJ; Keusch, GT; Ravreby, WD | 1 |
| Campos, ME; Rabinovich, S; Smith, IM | 1 |
| Kunz, LJ; Moellering, RC; Watson, BK | 1 |
| Benner, EJ; Bennett, JV; Brodie, JL; Kirby, WM | 1 |
| Moellering, RC; Weinberg, AN; Wennersten, C | 1 |
| Fomina, IP; Lobuseva, AN | 1 |
| Abramson, IJ; Smibert, RM | 1 |
| Hitzenberger, G | 1 |
| Welcker, ER | 1 |
| Benner, EJ; Morthland, V | 1 |
| Hohenegger, M; Ivansich, H | 1 |
| Hermans, PE; Martin, WJ; Washington, JA | 1 |
| Bdinkova, H; Hájková, L; Hejzlar, M; Janovská, D; Majorová, J; Paroubek, M; Výmola, F | 1 |
| Motlíková-Wagnerová, M; Vacek, V | 1 |
| Connolly, MG; Craven, DE; Hsieh, CR; Kollisch, NR; McCabe, WR | 1 |
| Coppens, L; Klastersky, J; Meunier-Carpentier, F; van der Auwera, P | 1 |
| Pelletier, LL | 1 |
| Mehta, JB; Thomas, E | 1 |
| Coppens, L | 1 |
| Murray, TW; Sande, MA; Strausbaugh, LJ | 1 |
| Friedman, RJ; Galambos, JT; Hersh, T; Mayer, IE | 1 |
| Caillon, J; Drugeon, HB; Juvin, ME | 1 |
| Chuard, C; Lew, DP; Rohner, P; Schaad, HJ; Vaudaux, P; Waldvogel, FA | 1 |
| Coe, CJ; Freeman, CD; Nicolau, DP; Nightingale, CH; Quintiliani, R | 1 |
| Chuard, C; Lew, DP; Vaudaux, P; Waldvogel, FA | 1 |
| Amsterdam, D; Beam, TR; Gorzynski, EA; Lawrence, T; Rotstein, C | 1 |
| Khardori, N; Wilson, K; Yassien, M | 1 |
| Daoud, EG; Flexner, C; Goodman, SN; Hartert, TV; Heldman, AW; Kowalski, TE; Lietman, PS; Petty, BG; Pompili, VJ; Ray, SC; Sisson, SD; Tidmore, WC; vom Eigen, KA | 1 |
| Garcia, R; Raad, I | 1 |
| Domaracki, BE; Evans, A; Fraimow, H; Preston, KE; Venezia, RA | 1 |
| Blard, JM; Finiels, PJ; Khoris, J; Milhaud, D; Pagès, M; Privat, JM | 1 |
| Igari, J; Nakamura, A; Oguri, T; Tabe, Y | 1 |
| Cereda, RF; Del' Alamo, L; Miranda, EA; Sader, HS; Tosin, I | 1 |
| Barriere, SL; Dunn, DL; Graham, DR; Kreter, B; Nichols, RL; Rodgers, A; Wilson, SE; Zervos, M | 1 |
| Hayashi, H; Kanamori, M; Matsumaru, H; Murakami, H; Ohta, T | 1 |
| Haraga, I; Nagayama, A; Nomura, S | 1 |
| Lacroix, C; LaPointe, G; Lavoie, MC; Mota-Meira, M | 1 |
| Domaracki, BE; Evans, AM; Venezia, RA | 1 |
| Chang, WN; Lu, CH | 1 |
| Fridkin, SK; Gaynes, RP; Hubert, SK; Lawton, R; McGowan, JE; Steward, CD; Tenover, FC; Wallace, D | 1 |
| Buescher, ES; Karlowicz, MG; Surka, AE | 1 |
| Bello, H; Dominguez, M; González, G; Mella, S; Sepúlveda, M; Zemelman, R | 1 |
| Choi, GH; Fujiwara, T; Komatsuzawa, H; Labischinski, H; Ohta, K; Sugai, M | 1 |
| DeGirolami, PC; Eliopoulos, GM; Gold, HS; Qian, Q; Sakoulas, G; Venkataraman, L | 1 |
| Archer, GL; Dickinson, TM; Finan, JE; Ko, D; Rosato, AE | 1 |
| Pfeltz, RF; Schmidt, JL; Wilkinson, BJ | 1 |
| Landau, M; Nucci, M; Pulcheri, W; Silveira, F; Spector, N | 1 |
| Igari, J; Nakamura, A; Tabe, Y | 1 |
| Bischoff, T; Climo, M; Edmond, MB; Ostrowsky, B; Tallent, SM; Wenzel, RP | 1 |
| Bruckner, DA; Kanatani, M; Linscott, AJ; Marlowe, EM | 1 |
| Gustafson, JE; Jayaswal, RK; Price, CT; Singh, VK; Wilkinson, BJ | 1 |
| Moyenuddin, M; Ohl, CA; Peacock, JE; Williamson, JC | 1 |
| Moran, GJ; Mount, J | 1 |
| Chatzidimitriou, M; Katikaridou, E; Kollaras, P; Koumentaki, E; Metallidis, S; Nikolaidis, P; Tourkantonis, A; Tsona, A | 1 |
| Boyle-Vavra, S; Challapalli, M; Daum, RS; Yin, S | 1 |
| Andrade-Baiocchi, S; Baiocchi, OC; Sader, HS; Tognim, MC | 1 |
| Jung, SI; Kiem, S; Kim, SW; Kim, YS; Lee, NY; Oh, WS; Peck, KR; Song, JH; Yun, HJ | 1 |
| Hiramatsu, K; Kuroda, H; Kuroda, M; Mori, H; Oshima, T; Takeuchi, F | 1 |
| Byl, B; De Gheldre, Y; Hallin, M; Jacobs, F; Maes, N; Struelens, MJ | 1 |
| Addison, RM; Cole, EC; Criger, DA; Dulaney, PD; Gaber, DJ; Leese, KE; Newell, MS; Rubino, JR; Wilkins, J; Wineinger, T | 1 |
| GRAY, J; WARREN, GH | 1 |
| HEJZLAR, M; JELINEK, J; VYMOLA, F | 1 |
| THEODORE, FH | 1 |
| FRIEDBERG, CK | 1 |
| MARTIN, WJ | 1 |
| PLATTNER, HC; SCHERER, J | 1 |
| Kokai-Kun, JF; Kusuma, C; Mond, JJ; Wu, JA | 1 |
| Chung, M; Clarke, N; Severin, A; Tabei, K; Tenover, F; Tomasz, A | 1 |
| Appelbaum, PC; Bozdogan, B; Chaitram, J; Clark, N; Jevitt, L; Killgore, G; McAllister, S; McDougal, LK; O'Hara, CM; Patel, JB; Tenover, FC; Weigel, LM | 1 |
| Dissemond, J; Esser, S; Goos, M; Schmid, EN; Witthoff, M | 1 |
| Adhikari, RP; Berger-Bächi, B; Cook, GM; Kobayashi, K; Scales, GC; Smith, JM | 1 |
| Carneiro, LAM; Merquior, VLC; Queiroz, MLP | 1 |
| Gultekin, N; Gurler, N; Kansiz, E; Kucukates, E; Nalan Karayel, E; Okuyan, E | 1 |
| Dias, MA; Konefal, SH; McLaughlin, MR; Wadie, GM | 1 |
| Chang, HW; Chang, WN; Chien, CC; Huang, CR; Lei, CB; Lu, CH; Wu, JJ | 1 |
| Arnold, FW; Wojda, B | 1 |
| Dalovisio, JR; Jiang, X; Tice, AD; Wynn, M | 1 |
| Diaz, E; Garnacho-Montero, J; Muñoz, E; Olona, M; Rello, J; Sa-Borges, M; Sirgo, G; Sole-Violan, J | 1 |
| Bento, M; Lew, DP; Schaad, HJ; Vaudaux, P | 1 |
| Lee, JH | 1 |
| English, BK; Maryniw, EM; Meals, EA; Talati, AJ | 1 |
| Hua, CZ; Li, JP; Li, S; Shang, SQ; Ye, H; Yu, HM | 1 |
| Archer, GL; Climo, MW; Fox, PM; Lampen, RJ; Stumpf, KS | 1 |
| Hryniewicz, W; Rózalska, B; Rózalska, S; Sadowska, B; Walencka, E | 1 |
| Karabay, O; Koçoğlu, E | 1 |
| Biedenbach, DJ; Fritsche, TR; Jones, RN; Ross, JE; Sader, HS | 1 |
| Chaudhury, A; Kumar, AG | 1 |
| Kelmani Chandrakanth, R; Patil, SA; Raju, S | 1 |
| Friedrich, L; Steinkraus, G; White, R | 1 |
| Cunha, Mde L; Martins, A | 1 |
| DiVittorio, KM; Hilkert, S; Hurley, S; Johnson, JR; Leevy, WM; Marquez, M; Morris, JD; O'Neil, EJ; Rosek, KD; Serazin, N; Smith, BD; Vakulenko, S | 1 |
| Arnold, C; Bosco, J; Clark, R; Shoemaker, C; Spitzer, AR | 1 |
| Ikonomidis, A; Karavasilis, V; Labrou, M; Maniatis, AN; Michail, G; Pournaras, S; Stathopoulos, C; Vasdeki, A | 1 |
| Khorvash, F; Mobasherizadeh, S; Mostafavizadeh, K | 1 |
| Bayer, AS; Cheung, AL; Memmi, G; Trotonda, MP; Xiong, YQ | 1 |
| Namias, N; Pizano, LR; Schulman, CI; Schuster, KM; Ward, CG; Wilson, D | 1 |
| Balaji, V; Beall, B; Joshi, HH; Thomas, K | 1 |
| Eliopoulos, GM; Karchmer, AW; Moellering, RC; Pillai, SK; Venkataraman, L; Wennersten, C | 1 |
| Eliopoulos, GM; Joukhadar, C; Moellering, RC; Pillai, S; Wennersten, C | 1 |
| Blick, SK; Lyseng-Williamson, KA | 1 |
| Chahales, P; Collin, M; Daniel, A; Euler, C; Fischetti, VA; Gorelick, KJ | 1 |
| Bikels-Goshen, T; Landau, E; Saguy, S; Shapira, R | 1 |
| Bloem, RM; Buma, P; Mathijssen, NM; Petit, PL; Pilot, P; Schreurs, BW | 1 |
| Beisser, PS; Croes, S; Deurenberg, RH; Neef, C; Stobberingh, EE; Terporten, PH | 1 |
| Jamil, N; Mirani, ZA | 1 |
| Diagre, D; Hussain, Z; John, MA; Milburn, S; Stuart, JI; Wilson, B | 1 |
| Choi, JG; Han, SH; Kang, OH; Keum, JH; Kim, SB; Kim, YG; Kwon, DY; Lee, JH; Mun, SH; Obiang-Obounou, BW; Park, CB; Shin, DW | 1 |
| Biek, D; Costello, AJ; Critchley, IA; Diekema, DJ; Doern, GV; Dohrn, CL; Heilmann, KP; Kroeger, JS; Riahi, F; Richter, SS | 1 |
| Bayer, AS; Chen, L; Kreiswirth, BN; McKinnell, J; Mishra, NN; Nast, CC; Rubio, A; Yeaman, MR | 1 |
| Bogomolova, NS; Bol'shakov, LV; Kuznetsova, SM; Oreshkina, TD | 1 |
| Barretti, P; Caramori, JC; Cunha, Mde L; Luengo, J; Montelli, AC; Oliveira, LG | 1 |
| Labrou, M; Michail, G; Ntokou, E; Pittaras, TE; Pournaras, S; Tsakris, A | 1 |
| Henry-Stanley, MJ; Hess, DJ; Wells, CL | 1 |
| López-Cabo, M; Rodríguez-Herrera, JJ; Saá-Ibusquiza, P; Vázquez-Sánchez, D | 1 |
| Bakar, NS; Basri, DF; Zin, NM | 1 |
| Durmus, NG; Kummer, KM; Leuba, K; Tarquinio, KM; Taylor, EN; Webster, TJ | 1 |
| Chan, YS; Chang, Y; Hsieh, PH; Lee, MS; Shih, HN; Ueng, SW | 1 |
| Brilene, T; Jürna-Ellam, M; Kalinina, J; Kiis, M; Kõljalg, S; Lõivukene, K; Lutsar, I; Metsvaht, T; Sepp, E; Soeorg, H; Stšepetova, J | 1 |
| Murray, KP; Newton, KL; Nonejuie, P; Pogliano, J; Rybak, MJ; Sakoulas, G; Vidaillac, C; Werth, BJ | 1 |
| Micota, B; Paszkiewicz, M; Różalska, B; Różalski, MI; Sadowska, B; Więckowska-Szakiel, M | 1 |
| Haque, N; Hoque, SM; Hossain, MA; Kabir, MR; Paul, SK; Rahman, A; Sultana, S | 1 |
| Chen, H; He, W; Li, H; Wang, H; Wang, Q; Wang, X; Zhang, F; Zhao, C | 1 |
| Godebo, G; Kibru, G; Tassew, H | 1 |
| Chang, CJ; Chen, HC; Chen, PY; Chuang, CC; Hsiao, CH; Huang, YC; Lin, HC; Ma, DH; Ong, SJ; Tan, HY; Yeh, LK | 1 |
| Dilworth, TJ; Dodd, M; Mercier, RC; Ryan, K; Sliwinski, J | 1 |
| Drew, RJ; Paulus, S | 1 |
| Barretti, P; Camargo, CH; Caramori, JC; Cunha, Mde L; Mondelli, AL; Montelli, AC | 1 |
| Campana, EH; Carvalhaes, CG; Gales, AC; Machado, AM; Nonato, B | 1 |
| Angelova, SN; Chernen'kaia, TV; Ershova, MG; Gostev, VV; Khokhlova, OE; Kruglov, AN; Molchanova, IV; Naumenko, ZS; Poletaeva, ED; Popenko, LN; Sidorenko, SV; Voroshilova, TM; Zakharova, IuA | 1 |
| Bezerra Neto, AM; Ferreira, EL; Leal, NC; Lima, JL; Loibman, SO; Maciel, MA; Rabelo, MA | 1 |
| Baatsen, P; Claessens, J; Merckx, R; Roriz, M; Van Eldere, J; Van Mellaert, L | 1 |
| Chung, HS; Lee, M; Park, S | 1 |
| Cushman, M; Hammac, GK; Mayhoub, AS; Mohammad, H; Monteleone, D; Reddy, PV; Seleem, MN | 1 |
| Miksza, KF; Morales, HM; Pecoit-Filho, R; Rocha, JL; Sakumoto, MH; Tuon, FF | 1 |
| Balzli, CL; Harnish, DA; Heimbuch, BK; Laning, ML; Wallace, WH; Wander, JD | 1 |
| Bartolomeu, AR; Brito, CI; Camargo, CH; Cunha, ML; Oliveira, A; Pereira, VC; Pinheiro, L | 1 |
| Aslan, H; Yapar, N | 1 |
| Camacho-Ortiz, A; Casillas-Vega, N; Garza-González, E; González, GM; Llaca-Díaz, J; Mendoza-Olazarán, S; Morfín-Otero, R; Rodríguez-Noriega, E; Villarreal-Treviño, L | 1 |
| Galvão, NN; Nogueira, PA; Orlandi, PP; Pieri, FA; Vargas, TF | 1 |
| Ahn, JW; Baek, YS; Jeon, J; Song, HJ | 1 |
| Ishii, M; Matsumoto, Y; Moriya, K; Okazaki, M; Sato, T; Sekimizu, K; Tabuchi, F; Tatsuno, K | 1 |
| Binatti, VB; Faria, YV; Hirata, R; Mattos-Guaraldi, AL; Pereira, JA; Pereira, PM; Ramos, JN; Santos, KR; Seabra, SH; Sued, BP; Vieira, VV | 1 |
| Barcenilla-Gaite, F; García-González, M; Jover-Sáenz, A; Ramírez Hidalgo, M | 1 |
| Maxson, T; Minogue, TD; Taylor-Howell, CL | 1 |
| Cavalcante, TTA; Costa, RA; de Carvalho, MG; de Sousa, OV; Júnior, FEAC; Melo, HM; Menezes, FGR; Vasconcelos, SECB | 1 |
| El-Mahdy, RH; Mashaly, GE | 1 |
| Dilworth, TJ; Elshaboury, RH; Jones, D; Munson, E | 1 |
| Peyrusson, F; Tulkens, PM; Van Bambeke, F | 1 |
| Bourgade, C; Chomton, M; Geslain, G; Le Bourgeois, F | 1 |
| Blaskovich, MAT; Cooper, MA; Gong, Y; Kavanagh, A; Ramu, S | 1 |
| Danelli, T; Duarte, FC; Grion, CMC; Kerbauy, G; Morguette, AEB; Perugini, MRE; Tavares, ER; Yamada-Ogatta, SF; Yamauchi, LM | 1 |
| Boyle, KK; Frisch, NB; Nodzo, SR | 1 |
| Almeida, B; Atilano Carvalho, P; Correia, FH; Lopes, S; Monteiro, A; Nunes, C; Resende, V | 1 |
| Dalponte, RS; Heluany, GCV; Madeira, K; Michels, M; Prado, CE | 1 |
| Abu El-Wafa, WM; Ibrahim, YM | 1 |
| Chantratita, N; Fukruksa, C; Muangpat, P; Sitthisak, S; Suwannaroj, M; Thanwisai, A; Vitta, A; Yimthin, T | 1 |
| Barbosa, LN; da Silva, GR; de Almeida Martins, L; de Paula Ferreira, LR; Dos Santos, IC; Dos Santos, MC; Gonçalves, DD; Otutumi, LK; Zaniolo, MM | 1 |
| Budzisz, E; Grazul, M; Hikisz, P; Namiecińska, E; Pasternak, B; Sadowska, B; Więckowska-Szakiel, M | 1 |
| Botelho, CV; Call, DR; Dos Santos Bersot, L; Grossi, JL; Nero, LA; Sovinski, ÂI | 1 |
| Bae, T; Bhowmick, A; Ghosh, A; Jain, S; Jeong, B | 1 |
| Fait, A; Ingmer, H; Mikkelsen, K; Palsson, BO; Poudel, S; Seif, Y; Wells, JM | 1 |
| Afshari, A; Hashemi, M; Mohamadi, S; Nematy, M; Norouzy, A; Taheri, S | 1 |
| Chang, SC; Hidrosollo, JH; Kao, CY; Lin, LC; Lu, JJ; Ou, YH | 1 |
| Chen, G; Lu, HZ | 1 |
| Lima, CSSDC; Lima, HAR; Silva, CSAGE | 1 |
| Iijima, J; Yamase, T | 1 |
6 review(s) available for vancomycin and oxacillin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Synthetic access to thiolane-based therapeutics and biological activity studies.
Topics: Alkaloids; Anti-Infective Agents; Antineoplastic Agents; Bacteria; Biological Products; Cell Survival; Fungi; Humans; Sesquiterpenes; Sulfhydryl Compounds | 2021 |
Cephalosporins, vancomycin, aminoglycosides and other drugs, especially in combination, for the treatment of methicillin-resistant staphylococcal infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Therapy, Combination; Glycopeptides; Imipenem; Methicillin; Norfloxacin; Oxacillin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Thienamycins; Vancomycin | 1986 |
Update on emerging infections: news from the Centers for Disease Control and Prevention.
Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; Centers for Disease Control and Prevention, U.S.; Community-Acquired Infections; Contraindications; Drug Resistance, Bacterial; Emergency Service, Hospital; Humans; Infection Control; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Penicillins; Practice Guidelines as Topic; Renal Dialysis; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; United States; United States Food and Drug Administration; Vancomycin; Vancomycin Resistance | 2003 |
NEWER ANTIMICROBIAL AGENTS HAVING CURRENT OR POTENTIAL CLINICAL APPLICATION.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Cephalothin; Colistin; Cycloserine; Demeclocycline; Erythromycin; Gentamicins; Griseofulvin; Humans; Kanamycin; Methicillin; Novobiocin; Oxacillin; Paromomycin; Penicillin V; Penicillins; Pharmacology; Ristocetin; Staphylococcal Infections; Toxicology; Troleandomycin; Vancomycin | 1964 |
Methicillin resistance in Staphylococcus aureus and coagulase-negative staphylococci: epidemiological and molecular aspects.
Topics: Anti-Bacterial Agents; Brazil; Coagulase; Disease Outbreaks; Humans; Methicillin; Methicillin Resistance; Oxacillin; Phenotype; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Vancomycin | 2007 |
6 trial(s) available for vancomycin and oxacillin
| Article | Year |
|---|---|
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Skin Diseases, Bacterial; Staphylococcus | 2008 |
[Incidence, frequency and resistance characteristics of methicillin-oxacillin resistant Staphylococcus aureus strains in Germany].
Topics: Ciprofloxacin; Clindamycin; Drug Resistance, Microbial; Fosfomycin; Germany; Humans; Imipenem; Methicillin; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Staphylococcus aureus; Teicoplanin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1992 |
Chromatographically purified vancomycin: therapy of serious infections caused by Staphylococcus aureus and other gram-positive bacteria.
Topics: Adolescent; Adult; Aged; Chromatography; Drug Resistance, Microbial; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Oxacillin; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1988 |
Double-blind, placebo-controlled study of oxacillin combined with rifampin in the treatment of staphylococcal infections.
Topics: Blood Bactericidal Activity; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Oxacillin; Random Allocation; Rifampin; Sepsis; Staphylococcal Infections; Vancomycin | 1985 |
Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Endocarditis, Bacterial; Female; Gentamicins; Humans; Infusions, Intravenous; Length of Stay; Male; Oxacillin; Penicillins; Prospective Studies; Rifampin; Staphylococcal Infections; Substance Abuse, Intravenous; Treatment Outcome; Vancomycin | 1996 |
Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infection Gr
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitalization; Humans; Male; Middle Aged; Oxacillin; Penicillins; Skin Diseases, Bacterial; Vancomycin; Virginiamycin | 1999 |
281 other study(ies) available for vancomycin and oxacillin
| Article | Year |
|---|---|
Substituted salicylanilides as inhibitors of two-component regulatory systems in bacteria.
Topics: Anti-Bacterial Agents; Bacillus subtilis; Bacterial Proteins; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Enterococcus faecium; Enzyme Inhibitors; Gram-Positive Bacteria; Luciferases; Methicillin Resistance; Microbial Sensitivity Tests; Phosphorylation; Protein Kinase Inhibitors; Protein Kinases; Salicylanilides; Spores, Bacterial; Staphylococcus aureus; Structure-Activity Relationship; Transcription Factors; Vancomycin | 1998 |
Novel inhibitors of bacterial two-component systems with gram positive antibacterial activity: pharmacophore identification based on the screening hit closantel.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacteria; Microbial Sensitivity Tests; Phosphorylation; Salicylanilides; Staphylococcus aureus; Structure-Activity Relationship | 1998 |
Amidino benzimidazole inhibitors of bacterial two-component systems.
Topics: Amidines; Anti-Bacterial Agents; Bacterial Proteins; Benzimidazoles; Combinatorial Chemistry Techniques; Gram-Positive Bacteria; Inhibitory Concentration 50; Microbial Sensitivity Tests; Protein Kinase Inhibitors; Protein Kinases; Signal Transduction | 2001 |
Antimicrobial activities of naphthazarins from Arnebia euchroma.
Topics: Anti-Bacterial Agents; Boraginaceae; Carcinoma, Hepatocellular; China; Drug Screening Assays, Antitumor; Electron Spin Resonance Spectroscopy; Enterococcus faecalis; Female; HeLa Cells; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Naphthoquinones; Nuclear Magnetic Resonance, Biomolecular; Ovarian Neoplasms; Plant Bark; Plants, Medicinal; Staphylococcus aureus; Stereoisomerism; Tumor Cells, Cultured; Vancomycin | 2002 |
Antibacterial, partially acetylated oligorhamnosides from Cleistopholis patens.
Topics: Annonaceae; Anti-Bacterial Agents; Gabon; Glycosides; Methicillin Resistance; Molecular Structure; Plant Leaves; Plants, Medicinal; Staphylococcus aureus | 2006 |
Solid-phase synthesis and antibacterial activity of hydroxycinnamic acid amides and analogues against methicillin-resistant Staphylococcus aureus and vancomycin-resistant S. aureus.
Topics: Amides; Anti-Bacterial Agents; Caffeine; Combinatorial Chemistry Techniques; Coumaric Acids; Drug Combinations; Ethanol; Methicillin Resistance; Oxacillin; Staphylococcus aureus; Vancomycin Resistance | 2006 |
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
Topics: Acetamides; Aminoglycosides; Biofilms; Catheters, Indwelling; Chloramphenicol; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Female; Fluoroquinolones; Humans; Linezolid; Macrolides; Microbial Sensitivity Tests; Micrococcus; Middle Aged; Morganella morganii; Oxazolidinones; Penicillins; Pseudomonas aeruginosa; Rifampin; Staphylococcus aureus; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Catheterization; Vancomycin; Vancomycin Resistance | 2007 |
In vitro antibacterial activity of the pyrrolopyrazolyl-substituted oxazolidinone RWJ-416457.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Linezolid; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Staphylococcus; Streptococcus | 2007 |
Effect of antibiotics on Staphylococcus aureus producing Panton-Valentine leukocidin.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Exotoxins; Leukocidins; Microbial Sensitivity Tests; Staphylococcus aureus | 2007 |
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.
Topics: Animals; Anti-Infective Agents; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Quinolones; Thiazoles | 2007 |
Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Combinations; Gentamicins; Humans; Microbial Sensitivity Tests; Monocytes; Oxacillin; Rifampin; Staphylococcus aureus; Vancomycin | 2007 |
In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea.
Topics: Acetamides; Anti-Infective Agents; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enzyme Inhibitors; Humans; In Vitro Techniques; Korea; Linezolid; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Pyridines; Staphylococcus; Staphylococcus aureus; Thienopyridines; Thiophenes | 2007 |
Lysostaphin in treatment of neonatal Staphylococcus aureus infection.
Topics: Animals; Animals, Suckling; Anti-Infective Agents, Local; Disease Models, Animal; Humans; Infant, Newborn; Lysostaphin; Methicillin Resistance; Microbial Sensitivity Tests; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2007 |
Polyamine effects on antibiotic susceptibility in bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Drug Resistance, Bacterial; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Polyamines; Spermine; Staphylococcus aureus | 2007 |
Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacterial Proteins; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Polymyxin B; Signal Transduction; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2007 |
In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Europe; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pyogenes; Vancomycin Resistance; Viridans Streptococci | 2007 |
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship | 2007 |
Functional characterization of TcaA: minimal requirement for teicoplanin susceptibility and role in Caenorhabditis elegans virulence.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Caenorhabditis elegans; Drug Resistance, Bacterial; Genetic Complementation Test; Membrane Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Promoter Regions, Genetic; Staphylococcus aureus; Survival Analysis; Teicoplanin; Virulence | 2007 |
Mutated response regulator graR is responsible for phenotypic conversion of Staphylococcus aureus from heterogeneous vancomycin-intermediate resistance to vancomycin-intermediate resistance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Gene Expression Regulation, Bacterial; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Oligonucleotide Array Sequence Analysis; Phenotype; Sequence Analysis, DNA; Signal Transduction; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2008 |
Role of a sodium-dependent symporter homologue in the thermosensitivity of beta-lactam antibiotic resistance and cell wall composition in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; Cell Wall; DNA Transposable Elements; Hot Temperature; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Penicillin-Binding Proteins; Sodium; Staphylococcus aureus; Symporters | 2008 |
Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Conjugation, Genetic; DNA Transposable Elements; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Humans; Michigan; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Restriction Mapping; Staphylococcal Infections; Staphylococcus aureus; Vancomycin Resistance | 2008 |
Spontaneous deletion of the methicillin resistance determinant, mecA, partially compensates for the fitness cost associated with high-level vancomycin resistance in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Culture Media; Gene Deletion; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Staphylococcus aureus; Vancomycin Resistance | 2008 |
Activities of daptomycin and comparative antimicrobials, singly and in combination, against extracellular and intracellular Staphylococcus aureus and its stable small-colony variant in human monocyte-derived macrophages and in broth.
Topics: Anti-Bacterial Agents; Cells, Cultured; Daptomycin; Gentamicins; Humans; Macrophages; Microbial Sensitivity Tests; Monocytes; Rifampin; Staphylococcus aureus | 2008 |
Methicillin-resistant Staphylococcus saprophyticus isolates carrying staphylococcal cassette chromosome mec have emerged in urogenital tract infections.
Topics: Bacterial Proteins; Chromosomes, Bacterial; Electrophoresis, Gel, Pulsed-Field; Methicillin Resistance; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus; Urinary Tract Infections | 2008 |
Comparison of the essential cellular functions of the two murA genes of Bacillus anthracis.
Topics: Alkyl and Aryl Transferases; Anti-Bacterial Agents; Bacillus anthracis; Bacterial Proteins; Drug Resistance, Bacterial; Fosfomycin; Inhibitory Concentration 50; Microbial Sensitivity Tests; RNA, Antisense | 2008 |
First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; Drug Resistance, Bacterial; Humans; Linezolid; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Oxazolidinones; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Comparative study of the susceptibilities of major epidemic clones of methicillin-resistant Staphylococcus aureus to oxacillin and to the new broad-spectrum cephalosporin ceftobiprole.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
Staphylococcus aureus cell wall stress stimulon gene-lacZ fusion strains: potential for use in screening for cell wall-active antimicrobials.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cell Wall; Gene Expression Regulation, Bacterial; Lac Operon; Microbial Sensitivity Tests; Oxacillin; Penicillin-Binding Proteins; Recombinant Fusion Proteins; Staphylococcus aureus | 2008 |
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; United States | 2008 |
Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; Drug Resistance, Bacterial; Humans; Membrane Fluidity; Membrane Potentials; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Phenotype; Vancomycin | 2008 |
In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
Topics: Acetamides; Anti-Bacterial Agents; Binding Sites; Drug Resistance, Bacterial; Enterococcus; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Molecular; Oxazolidinones; Prodrugs; Staphylococcus aureus | 2008 |
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Chromosome Walking; DNA-Binding Proteins; Genetic Engineering; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a
Topics: Anti-Bacterial Agents; Cell Line; Cystic Fibrosis; Dose-Response Relationship, Drug; Fusidic Acid; Gentamicins; Humans; Macrophages; Microbial Sensitivity Tests; Oxacillin; Phenotype; Protein Binding; Staphylococcus aureus; Thymidine | 2009 |
Functional characterization of the sigmaB-dependent yabJ-spoVG operon in Staphylococcus aureus: role in methicillin and glycopeptide resistance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Gene Deletion; Gene Expression Regulation, Bacterial; Glycopeptides; Humans; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Operon; Sigma Factor; Staphylococcus aureus | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.
Topics: Anti-Bacterial Agents; beta-Lactams; Blotting, Northern; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Imipenem; Microbial Sensitivity Tests; Mutation; Sequence Analysis, DNA; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
Topics: Anti-Bacterial Agents; Azepines; Bacteria, Anaerobic; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 2009 |
In vitro activity of TR-700, the active ingredient of the antibacterial prodrug TR-701, a novel oxazolidinone antibacterial agent.
Topics: Anti-Bacterial Agents; Bacteria; Enterococcus; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Oxazolidinones; Staphylococcus; Streptococcus | 2009 |
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
Topics: Anti-Bacterial Agents; China; Cities; Drug Resistance, Multiple, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2009 |
Isoplatensimycin: Synthesis and biological evaluation.
Topics: Adamantane; Aminobenzoates; Anilides; Anti-Bacterial Agents; Enterococcus; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Vancomycin Resistance | 2009 |
In vitro activities of panduratin A against clinical Staphylococcus strains.
Topics: Anti-Bacterial Agents; Chalcones; Humans; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus; Zingiberaceae | 2009 |
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Glycopeptides; Gram-Positive Bacteria; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus | 2009 |
Norselic acids A-E, highly oxidized anti-infective steroids that deter mesograzer predation, from the Antarctic sponge Crella sp.
Topics: Animals; Antarctic Regions; Anti-Infective Agents; Candida albicans; Enterococcus faecium; Leishmania; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Porifera; Staphylococcal Infections; Steroids; Vancomycin Resistance | 2009 |
Identification of a plasmid-borne resistance gene cluster comprising the resistance genes erm(T), dfrK, and tet(L) in a porcine methicillin-resistant Staphylococcus aureus ST398 strain.
Topics: Animals; Anti-Bacterial Agents; Lincosamides; Macrolides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Sequence Data; Multigene Family; Plasmids; Streptogramin B; Swine; Tetracycline Resistance; Trimethoprim | 2010 |
Comparative in vitro activities of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, and other quinolones against clinical isolates.
Topics: Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Quinolones; Taiwan | 2010 |
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
Topics: Bacterial Proteins; Drug Resistance, Bacterial; Indoles; Microbial Sensitivity Tests; Mutation; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus aureus; Structure-Activity Relationship; Substrate Specificity | 2010 |
7-Phenylplatensimycin and 11-methyl-7-phenylplatensimycin: more potent analogs of platensimycin.
Topics: Adamantane; Aminobenzoates; Anilides; Anti-Bacterial Agents; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Staphylococcus aureus; Structure-Activity Relationship | 2010 |
Potent antimicrobial activity of 3-(4,5-diaryl-1H-imidazol-2-yl)-1H-indole derivatives against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Infective Agents; Enterococcus faecalis; Enterococcus faecium; Gram-Negative Bacteria; Gram-Positive Bacteria; Indoles; Methicillin-Resistant Staphylococcus aureus; Vancomycin | 2010 |
Development of daptomycin nonsusceptibility with heterogeneous vancomycin-intermediate resistance and oxacillin susceptibility in methicillin-resistant Staphylococcus aureus during high-dose daptomycin treatment.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Oxacillin; Oxazolidinones; Teicoplanin; Vancomycin Resistance | 2010 |
Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1.
Topics: Anti-Bacterial Agents; Enzyme Inhibitors; Inhibitory Concentration 50; Microbial Sensitivity Tests; Protein Structure, Secondary; Protein Structure, Tertiary; Staphylococcus aureus; Tetrahydrofolate Dehydrogenase | 2010 |
Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Cytotoxins; Methicillin-Resistant Staphylococcus aureus; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Trans-Activators; Virulence | 2010 |
An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; Drug Resistance, Multiple, Bacterial; Mutation; Polymorphism, Single Nucleotide; Staphylococcus aureus; Vancomycin | 2010 |
In vitro and in vivo activities of LCB01-0371, a new oxazolidinone.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Infections; Gram-Positive Bacteria; Linezolid; Male; Mice; Mice, Inbred ICR; Oxazolidinones; Staphylococcus aureus; Vancomycin | 2010 |
Identification and characterization of the multidrug resistance gene cfr in a Panton-Valentine leukocidin-positive sequence type 8 methicillin-resistant Staphylococcus aureus IVa (USA300) isolate.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Drug Resistance, Multiple, Bacterial; Exotoxins; Leukocidins; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Molecular Sequence Data; Plasmids | 2010 |
Exploration of the activity of 7-pyrrolidino-8-methoxyisothiazoloquinolones against methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Anti-Bacterial Agents; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Escherichia coli; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyrrolidines; Quinolones; Stereoisomerism; Structure-Activity Relationship; Thiazoles; Topoisomerase II Inhibitors | 2011 |
Synthesis and biological activity of novel N-cycloalkyl-(cycloalkylaryl)-2-[(3-R-2-oxo-2H-[1,2,4]triazino[2,3-c]quinazoline-6-yl)thio]acetamides.
Topics: Acetamides; Anti-Bacterial Agents; Antineoplastic Agents; Bacteria; Bacterial Infections; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Microbial Sensitivity Tests; Neoplasms; Quinazolines | 2011 |
Antibacterial activity of substituted dibenzo[a,g]quinolizin-7-ium derivatives.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Berberine; Cytoskeletal Proteins; Enterococcus faecalis; Microbial Sensitivity Tests; Quinolizines; Staphylococcus aureus; Structure-Activity Relationship | 2012 |
Antibacterial activity of substituted 5-methylbenzo[c]phenanthridinium derivatives.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Benzophenanthridines; Cytoskeletal Proteins; Enterococcus faecalis; Isoquinolines; Microbial Sensitivity Tests; Phenanthridines; Staphylococcus aureus | 2012 |
3-Phenyl substituted 6,7-dimethoxyisoquinoline derivatives as FtsZ-targeting antibacterial agents.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cytoskeletal Proteins; Enterococcus faecalis; HEK293 Cells; Humans; Isoquinolines; Molecular Targeted Therapy; Staphylococcus aureus | 2012 |
Antimicrobial activity of various 4- and 5-substituted 1-phenylnaphthalenes.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Enterococcus faecalis; Microbial Sensitivity Tests; Molecular Structure; Naphthalenes; Staphylococcus aureus; Structure-Activity Relationship | 2013 |
Substituted 1,6-diphenylnaphthalenes as FtsZ-targeting antibacterial agents.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cytoskeletal Proteins; Enterococcus faecalis; Microbial Sensitivity Tests; Molecular Structure; Naphthalenes; Polymerization; Staphylococcus aureus | 2013 |
Synthesis and evaluation of antimicrobial activity of hydrazones derived from 3-oxido-1H-imidazole-4-carbohydrazides.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Bacteria; Cell Line; Cell Proliferation; Cell Survival; Cyclic N-Oxides; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fungi; HeLa Cells; Humans; Hydrazines; Hydrazones; Imidazoles; Mice; Molecular Structure; Structure-Activity Relationship | 2013 |
Synthesis and antimicrobial activity of imidazole and pyridine appended cholestane-based conjugates.
Topics: Anti-Infective Agents; Cholestanes; Gram-Negative Bacteria; Gram-Positive Bacteria; Imidazoles; Microbial Sensitivity Tests; Pyridines; Staphylococcus epidermidis | 2013 |
Antibacterial activity of quinoxalines, quinazolines, and 1,5-naphthyridines.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Naphthyridines; Quinazolines; Quinoxalines; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2013 |
Identification of elaiophylin derivatives from the marine-derived actinomycete Streptomyces sp. 7-145 using PCR-based screening.
Topics: Anti-Bacterial Agents; Macrolides; Marine Biology; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Polymerase Chain Reaction; Streptomyces; Vancomycin | 2013 |
Structure-activity relationship for the oxadiazole class of antibiotics.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Oxadiazoles; Staphylococcus aureus; Structure-Activity Relationship | 2015 |
Synthesis and antimicrobial activity of chloramphenicol-polyamine conjugates.
Topics: Acetyltransferases; Anti-Bacterial Agents; Bacterial Proteins; Chloramphenicol; Enzyme Assays; Escherichia coli; Gene Expression; Kinetics; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Phthalic Anhydrides; Spermidine; Succinic Anhydrides | 2015 |
Deprotometalation-iodolysis and computed CH acidity of 1,2,3- and 1,2,4-triazoles. Application to the synthesis of resveratrol analogues.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Conformation; Resveratrol; Stilbenes; Triazoles | 2015 |
Domino Synthesis of Embelin Derivatives with Antibacterial Activity.
Topics: Aldehydes; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzoquinones; Catalysis; Gram-Positive Bacteria; Molecular Structure; Proline; Staphylococcus aureus; Stereoisomerism | 2016 |
Polybrominated Diphenyl Ethers: Structure Determination and Trends in Antibacterial Activity.
Topics: Animals; Anti-Bacterial Agents; Dysidea; Enterococcus faecium; Escherichia coli; Halogenated Diphenyl Ethers; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Papua New Guinea; Staphylococcus aureus; Structure-Activity Relationship | 2016 |
Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium smegmatis; Triazenes | 2017 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Arylthiazole antibiotics targeting intracellular methicillin-resistant Staphylococcus aureus (MRSA) that interfere with bacterial cell wall synthesis.
Topics: Animals; Anti-Bacterial Agents; Bacillus subtilis; Cell Line; Cell Wall; Dose-Response Relationship, Drug; Macrophages; Methicillin-Resistant Staphylococcus aureus; Mice; Molecular Structure; Structure-Activity Relationship; Thiazoles | 2017 |
Design, synthesis and biological evaluation of antimicrobial diarylimine and -amine compounds targeting the interaction between the bacterial NusB and NusE proteins.
Topics: Aniline Compounds; Anti-Bacterial Agents; Bacterial Proteins; Benzylamines; Caco-2 Cells; Drug Design; Erythrocytes; Gram-Negative Bacteria; Gram-Positive Bacteria; HeLa Cells; Hemolysis; Humans; Keratinocytes; Microbial Sensitivity Tests; Molecular Structure; Protein Binding; Schiff Bases; Structure-Activity Relationship; Transcription Factors | 2019 |
Two optimized antimicrobial peptides with therapeutic potential for clinical antibiotic-resistant Staphylococcus aureus.
Topics: Anti-Infective Agents; Antimicrobial Cationic Peptides; Biofilms; HEK293 Cells; Hemolysis; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections | 2019 |
Antibacterial and ATP Synthesis Modulating Compounds from
Topics: Abietanes; Adenosine Triphosphate; Anti-Bacterial Agents; Diterpenes; Enterococcus faecalis; Flavonoids; Humans; Lactones; Molecular Structure; Plant Components, Aerial; Salvia | 2020 |
Synthesis of novel monocarbonyl curcuminoids, evaluation of their efficacy against MRSA, including ex vivo infection model and their mechanistic studies.
Topics: 3T3 Cells; Animals; Anti-Bacterial Agents; Chemistry Techniques, Synthetic; Diarylheptanoids; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Viability | 2020 |
Paecilosetin Derivatives as Potent Antimicrobial Agents from
Topics: Anti-Infective Agents; Cordyceps; Humans; Microbial Sensitivity Tests; Molecular Structure; Paecilomyces; Pyrrolidinones | 2020 |
Lead optimization of 8-(methylamino)-2-oxo-1,2-dihydroquinolines as bacterial type II topoisomerase inhibitors.
Topics: Anti-Bacterial Agents; Cell Survival; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Hep G2 Cells; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Quinolines; Streptococcus pneumoniae; Structure-Activity Relationship; Topoisomerase II Inhibitors; Transcriptional Regulator ERG; Vancomycin-Resistant Enterococci | 2020 |
Discovery of novel N
Topics: A549 Cells; Animals; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Cytidine; Drug Discovery; Fungi; Humans; Microbial Sensitivity Tests | 2021 |
4-4-(Anilinomethyl)-3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-ylbenzoic acid derivatives as potent anti-gram-positive bacterial agents.
Topics: Aniline Compounds; Anti-Bacterial Agents; Biofilms; Cell Line; Cell Survival; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacteria; Humans; Liver; Microbial Sensitivity Tests; Pyrazoles; Staphylococcus aureus; Structure-Activity Relationship | 2021 |
Antimicrobial, modulatory, and antibiofilm activity of tt-farnesol on bacterial and fungal strains of importance to human health.
Topics: Anti-Bacterial Agents; Biofilms; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship | 2021 |
Design, synthesis, and antibacterial activity of
Topics: | 2021 |
SF
Topics: | 2021 |
Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cell Survival; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Multidrug Resistance-Associated Proteins; Quinazolines; Staphylococcus aureus; Structure-Activity Relationship; THP-1 Cells | 2022 |
Induction and prevention of experimental arteriovenous fistula infections.
Topics: Animals; Arteriovenous Fistula; Disease Models, Animal; Oxacillin; Rabbits; Staphylococcal Infections; Vancomycin | 1979 |
The efficacy of rifampin as adjunctive therapy in selected cases of staphylococcal endocarditis.
Topics: Adult; Endocarditis, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Oxacillin; Rifampin; Staphylococcal Infections; Vancomycin | 1978 |
Comparative in-vitro activity of RP 59500.
Topics: Bacteria; Ciprofloxacin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Gentamicins; In Vitro Techniques; Microbial Sensitivity Tests; Oxacillin; Vancomycin; Virginiamycin | 1992 |
Platelet microbicidal protein enhances antibiotic-induced killing of and postantibiotic effect in Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Blood Proteins; Drug Synergism; In Vitro Techniques; Microbial Sensitivity Tests; Oxacillin; Rabbits; Staphylococcus aureus; Vancomycin | 1992 |
Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Diffusion Chambers, Culture; Disease Models, Animal; Drug Resistance, Microbial; Fleroxacin; Foreign Bodies; Gentamicins; Kinetics; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Rats; Rats, Inbred Strains; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1991 |
Treatment evaluation of experimental staphylococcal infections: comparison of beta-lactam, lipopeptide, and glycopeptide antimicrobial therapy.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefamandole; Cefoperazone; Cephalothin; Daptomycin; Disease Models, Animal; Female; Glycopeptides; Oxacillin; Peptides; Rabbits; Staphylococcal Infections; Sulbactam; Teicoplanin; Vancomycin | 1990 |
Time-kill studies with oxacillin, vancomycin, and teicoplanin versus Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Glycopeptides; Humans; Oxacillin; Staphylococcus aureus; Teicoplanin; Vancomycin | 1990 |
In vitro activity of LY264826, a new glycopeptide antibiotic, against gram-positive bacteria isolated from patients with cancer.
Topics: Anti-Bacterial Agents; Bacterial Infections; Culture Media; Gram-Positive Bacteria; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Neoplasms; Oxacillin; Teicoplanin; Vancomycin | 1990 |
Comparative in vitro activities of teicoplanin, vancomycin, oxacillin, and other antimicrobial agents against bacteremic isolates of gram-positive cocci.
Topics: Anti-Bacterial Agents; Glycopeptides; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Oxacillin; Sepsis; Teicoplanin; Vancomycin | 1989 |
Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Microbial; Evaluation Studies as Topic; Glycopeptides; Microbial Sensitivity Tests; Oxacillin; Peptides; Staphylococcus; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 1989 |
Comparative study of clindamycin, imipenem, oxacillin and vancomycin in the infected granuloma pouch model.
Topics: Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Clindamycin; Granuloma; Imipenem; Male; Microbial Sensitivity Tests; Oxacillin; Rats; Rats, Inbred Strains; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1989 |
Clostridium perfringens type A. Comparison of in vitro and in vivo activity of twelve antimicrobial drugs.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Clostridium perfringens; Fosfomycin; Gas Gangrene; Imipenem; Metronidazole; Mice; Microbial Sensitivity Tests; Oxacillin; Penicillin G; Thienamycins; Vancomycin | 1986 |
Short-course therapy for catheter-associated Staphylococcus aureus bacteremia.
Topics: Anti-Bacterial Agents; Catheterization; Cephalothin; Cross Infection; Endocarditis, Bacterial; Follow-Up Studies; Humans; Oxacillin; Prospective Studies; Recurrence; Risk Factors; Sepsis; Staphylococcal Infections; Time Factors; Vancomycin | 1989 |
In vitro antistaphylococcal activity of teicoplanin and ciprofloxacin in peritoneal dialysis effluent.
Topics: Anti-Bacterial Agents; Ascitic Fluid; Cefazolin; Ciprofloxacin; Glycopeptides; Humans; Oxacillin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcal Infections; Staphylococcus; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 1986 |
Antistaphylococcal activity of a cyclic peptide, LY146032, and vancomycin.
Topics: Anti-Bacterial Agents; Daptomycin; Humans; Microbial Sensitivity Tests; Oxacillin; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 1986 |
In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocci.
Topics: Ampicillin; Anti-Bacterial Agents; Daptomycin; Kinetics; Microbial Sensitivity Tests; Oxacillin; Staphylococcus; Streptococcus; Vancomycin | 1987 |
Comparative in vitro activity of LY146032 (daptomycin), a new lipopeptide antimicrobial.
Topics: Ampicillin; Anti-Bacterial Agents; Clostridium; Daptomycin; Glycopeptides; Gram-Positive Bacteria; Humans; Listeria monocytogenes; Microbial Sensitivity Tests; Oxacillin; Peptides; Staphylococcus; Streptococcus; Teicoplanin; Vancomycin | 1987 |
In-vitro antimicrobial activity of enoxacin in combination with eight other antibiotics against Pseudomonas aeruginosa, Enterobacteriaceae and Staphylococcus aureus.
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefsulodin; Clindamycin; Drug Combinations; Drug Synergism; Enoxacin; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Naphthyridines; Oxacillin; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Vancomycin | 1987 |
Antimicrobial prophylaxis in ear surgery.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Cephalothin; Child; Data Interpretation, Statistical; Ear; Female; Graft Survival; Humans; Male; Oxacillin; Premedication; Prospective Studies; Surgical Wound Infection; Vancomycin | 1988 |
Oxacillin, cephalothin, and vancomycin tube macrodilution MBC result reproducibility and equivalence to MIC results for methicillin-susceptible and reputedly tolerant Staphylococcus aureus isolates.
Topics: Anti-Bacterial Agents; Cephalothin; Culture Media; Methicillin; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Staphylococcus aureus; Vancomycin | 1988 |
[Methicillin-resistant Staphylococcus aureus].
Topics: Methicillin; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Staphylococcus aureus; Vancomycin | 1987 |
Bactericidal activity and killing rate of serum against gram-positive cocci in volunteers receiving imipenem, oxacillin, vancomycin or ampicillin plus gentamicin.
Topics: Adult; Ampicillin; Blood Bactericidal Activity; Gentamicins; Gram-Positive Bacteria; Humans; Imipenem; Oxacillin; Penicillin Resistance; Staphylococcus; Streptococcus; Thienamycins; Vancomycin | 1987 |
Comparison of agar disk diffusion, microdilution broth, and agar dilution for testing antimicrobial susceptibility of coagulase-negative staphylococci.
Topics: Anti-Bacterial Agents; Cephalosporins; Coagulase; Culture Media; Drug Resistance, Microbial; Fusidic Acid; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Rifampin; Sodium Chloride; Staphylococcus; Temperature; Vancomycin | 1987 |
In vitro evaluation of clindamycin in combination with oxacillin, rifampin, or vancomycin against Staphylococcus aureus.
Topics: Clindamycin; Drug Combinations; Drug Synergism; Microbial Sensitivity Tests; Oxacillin; Rifampin; Staphylococcus aureus; Time Factors; Vancomycin | 1986 |
Antibiotic tolerance of Staphylococcus epidermidis.
Topics: Anti-Bacterial Agents; Cefazolin; Cephalothin; Drug Tolerance; Methicillin; Microbial Sensitivity Tests; Nafcillin; Oxacillin; Staphylococcus epidermidis; Vancomycin | 1985 |
The role of autolysins in cell death.
Topics: Anti-Bacterial Agents; Autoantibodies; Bacteriolysis; Carbon Radioisotopes; Cell Wall; Choline; Cycloserine; Detergents; Dose-Response Relationship, Drug; Ethanolamines; Lysine; Mutation; Nitrosoguanidines; Oxacillin; Penicillin G; Penicillins; Phosphatidylethanolamines; Streptococcus pneumoniae; Time Factors; Vancomycin | 1974 |
Growing clinical significance of methcillin-resistant Staphylococcus aureus.
Topics: Cephalosporins; Cross Infection; Humans; Methicillin; Oxacillin; Penicillin Resistance; Penicillins; Staphylococcal Infections; Staphylococcus; Vancomycin | 1968 |
In vitro studies of the action of antibiotics on Rickettsia prowazeki by two basic methods of cell culture.
Topics: Amphotericin B; Ampicillin; Animals; Anti-Bacterial Agents; Bacteriological Techniques; Chick Embryo; Chloramphenicol; Culture Techniques; Dimethyl Sulfoxide; Doxycycline; Erythromycin; Gentamicins; Kanamycin; Minocycline; Neomycin; Oxacillin; Penicillin G; Rickettsia Infections; Rickettsia prowazekii; Rifampin; Streptomycin; Tetracycline; Ultrafiltration; Vancomycin | 1974 |
Effect of lidocaine on the antibacterial activity of seven antibiotics.
Topics: Anti-Bacterial Agents; Carbenicillin; Cephaloridine; Cephalothin; Drug Interactions; Eye Diseases; Gentamicins; Hydrogen-Ion Concentration; Lidocaine; Methicillin; Oxacillin; Pseudomonas aeruginosa; Staphylococcus; Vancomycin | 1974 |
[Elimination of antibiotics and sulfonamides from the human organism during renal insufficiency and the therapeutic consequences].
Topics: Ampicillin; Anti-Bacterial Agents; Cephaloridine; Cephalothin; Chloramphenicol; Creatinine; Dicloxacillin; Gentamicins; Humans; Kanamycin; Kidney Diseases; Methicillin; Novobiocin; Oxacillin; Penicillin G; Penicillins; Polymyxins; Streptomycin; Sulfonamides; Tetracycline; Vancomycin | 1969 |
Nonenterococcal group-D streptococcal endocarditis caused by Streptococcus bovis.
Topics: Adult; Aged; Ampicillin; Cephalosporins; Child; Chloramphenicol; Drug Therapy, Combination; Endocarditis, Bacterial; Erythromycin; Female; Gastrointestinal Diseases; Gentamicins; Humans; Kanamycin; Lincomycin; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Oxacillin; Penicillin G; Streptococcal Infections; Streptococcus; Streptomycin; Tetracycline; Urologic Diseases; Vancomycin | 1974 |
[Actual medical importance and antibiotic resistance of staphylococci].
Topics: Ampicillin; Cephaloridine; Chloramphenicol; Erythromycin; Fusidic Acid; Gentamicins; Germany, West; Lincomycin; Novobiocin; Oxacillin; Penicillin G; Penicillin Resistance; Staphylococcus; Streptomycin; Sulfamethoxazole; Tetracycline; Trimethoprim; Vancomycin | 1972 |
Antibiotic sensitivity of staphylococci isolated in Ulanbator. On the occasion of the 50th anniversary of the Mongolian health services.
Topics: Anti-Bacterial Agents; Cephaloridine; Chloramphenicol; Erythromycin; Fusidic Acid; Humans; Kanamycin; Leucomycins; Lincomycin; Microbial Sensitivity Tests; Mongolia; Neomycin; Oxacillin; Penicillin Resistance; Penicillins; Rifampin; Staphylococcal Infections; Staphylococcus; Streptomycin; Tetracycline; Vancomycin | 1972 |
[Methicillin-resistant staphylococci: biological properties and sensitivity to antibiotics].
Topics: Ampicillin; Anti-Bacterial Agents; Carbenicillin; Cephaloridine; Chloramphenicol; Dicloxacillin; Erythromycin; Fusidic Acid; Gentamicins; Kanamycin; Methicillin; Oxacillin; Penicillin G; Penicillin Resistance; Penicillinase; Rifampin; Staphylococcus; Streptomycin; Tetracycline; Vancomycin | 1973 |
Group D streptococcal bacteremia, with emphasis on the incidence and presentation of infections due to Streptococcus bovis.
Topics: Ampicillin; Anti-Bacterial Agents; Blood Bactericidal Activity; Cephalothin; Clindamycin; Endocarditis, Bacterial; Endocarditis, Subacute Bacterial; Erythromycin; Gentamicins; Humans; New York City; Oxacillin; Penicillins; Sepsis; Streptococcal Infections; Streptococcus; Streptomycin; Tetracycline; Vancomycin | 1973 |
Therapy of experimental staphylococcal infection with antibiotic combinations.
Topics: Animals; Anti-Bacterial Agents; Chloramphenicol; Disease Models, Animal; Drug Antagonism; Drug Synergism; Drug Therapy, Combination; Gentamicins; Lincomycin; Mice; Oxacillin; Staphylococcal Infections; Vancomycin | 1974 |
Endocarditis due to group D streptococci. Comparison of disease caused by streptococcus bovis with that produced by the enterococci.
Topics: Ampicillin; Boston; Cephaloridine; Cephalothin; Chloramphenicol; Endocarditis, Bacterial; Erythromycin; Gentamicins; Humans; Kanamycin; Methicillin; Microbial Sensitivity Tests; Oxacillin; Penicillins; Retrospective Studies; Species Specificity; Streptococcal Infections; Streptococcus; Vancomycin | 1974 |
Simplified, accurate method for antibiotic assay of clinical specimens.
Topics: Ampicillin; Anti-Bacterial Agents; Bacillus subtilis; Bacteriological Techniques; Bordetella; Cephaloridine; Cephalothin; Cloxacillin; Colistin; Culture Media; Dicloxacillin; Humans; Kanamycin; Methicillin; Nafcillin; Oxacillin; Penicillin G; Penicillins; Sarcina; Tetracycline; Vancomycin | 1966 |
Studies on antibiotic synergism against enterococci. I. Bacteriologic studies.
Topics: Anti-Bacterial Agents; Bacitracin; Cell Wall; Cephalothin; Chloramphenicol; Colistin; Cycloserine; Drug Synergism; Edetic Acid; Enterococcus faecalis; Erythromycin; Gentamicins; Kanamycin; L Forms; Methicillin; Oxacillin; Penicillin Resistance; Penicillins; Streptomycin; Tetracycline; Vancomycin | 1971 |
[Kinetic specification of some antibiotics in cases with kidney insufficiency].
Topics: Ampicillin; Anti-Bacterial Agents; Carbenicillin; Cephalosporins; Chloramphenicol; Erythromycin; Gentamicins; Humans; Kanamycin; Kidney Diseases; Oxacillin; Penicillins; Streptomycin; Tetracycline; Vancomycin | 1972 |
Method of testing antibiotic sensitivity of spirochaetes, using antibiotic discs.
Topics: Ampicillin; Anti-Bacterial Agents; Bacitracin; Cephalothin; Chloramphenicol; Cloxacillin; Culture Media; Erythromycin; Kanamycin; Methicillin; Methods; Microbial Sensitivity Tests; Nafcillin; Neomycin; Novobiocin; Oleandomycin; Oxacillin; Penicillins; Ristocetin; Spirochaeta; Streptomycin; Tetracycline; Treponema; Vancomycin | 1972 |
[Antibiotic therapy in disturbed kidney function].
Topics: Ampicillin; Anti-Bacterial Agents; Cephaloridine; Cephalothin; Creatinine; Erythromycin; Gentamicins; Glomerular Filtration Rate; Humans; Kanamycin; Kidney Diseases; Kidney Function Tests; Lincomycin; Oxacillin; Penicillin G; Streptomycin; Tetracycline; Vancomycin | 1971 |
[On contemporary rational penicillin treatment].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Ascorbic Acid; Child; Cloxacillin; Female; Humans; Kanamycin; Male; Methicillin; Oxacillin; Penicillin G; Penicillin Resistance; Penicillins; Ristocetin; Staphylococcal Infections; Streptococcal Infections; Vancomycin | 1965 |
Methicillin-resistant Staphylococcus aureus. Antimicrobial susceptibility.
Topics: Adult; Cephaloridine; Cephalothin; Chloramphenicol; Erythromycin; Humans; Lincomycin; Male; Methicillin; Oxacillin; Penicillin Resistance; Staphylococcus; Vancomycin | 1967 |
[Staphylococcal sepsis with bacterial meningoencephalitis and hypokalemic kidney damage treated with vancomycin].
Topics: Cephalothin; Chloramphenicol; Humans; Hypokalemia; Male; Meningoencephalitis; Middle Aged; Oxacillin; Penicillin G; Penicillin Resistance; Polyuria; Potassium; Sepsis; Staphylococcal Infections; Vancomycin; Vasopressins | 1969 |
In vitro susceptibility of staphylococci and streptococci and influence of agar media on minimum inhibitory concentration.
Topics: Agar; Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Culture Media; Erythromycin; Humans; Lincomycin; Microbial Sensitivity Tests; Oxacillin; Penicillin G; Staphylococcus; Streptococcus; Tetracycline; Vancomycin | 1970 |
Cephaloridine. II. The effect of cephaloridine on experimental model infections.
Topics: Animals; Cephaloridine; Chloramphenicol; Cloxacillin; Erythromycin; Guinea Pigs; Injections, Intramuscular; Kanamycin; Methicillin; Mice; Models, Biological; Nafcillin; Oxacillin; Proteus Infections; Rabbits; Staphylococcal Infections; Streptococcal Infections; Vancomycin | 1967 |
Problem of efficient initial therapy of acute staphylococcal endocarditis. (Attempt at approach to rational treatment.).
Topics: Anti-Bacterial Agents; Cephaloridine; Endocarditis, Bacterial; Methicillin; Oxacillin; Staphylococcal Infections; Vancomycin | 1967 |
Vancomycin treatment of bacteremia caused by oxacillin-resistant Staphylococcus aureus: comparison with beta-lactam antibiotic treatment of bacteremia caused by oxacillin-sensitive Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cross Infection; Female; Humans; Male; Middle Aged; Oxacillin; Penicillin Resistance; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1983 |
Vancomycin therapy of oxacillin-resistant Staphylococcus aureus infections.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Humans; Middle Aged; Oxacillin; Penicillin Resistance; Respiratory Tract Infections; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1983 |
Lack of reproducibility of macrodilution MBCs for Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cephalothin; Methicillin; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Staphylococcus aureus; Vancomycin | 1984 |
Pseudomembranous colitis due to oxacillin therapy.
Topics: Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Middle Aged; Oxacillin; Vancomycin | 1984 |
[Treatment of severe infections and septicemia caused by S. aureus (author's transl)].
Topics: Anti-Bacterial Agents; Cefamandole; Cephalosporins; Drug Therapy, Combination; Humans; Oxacillin; Penicillin Resistance; Sepsis; Staphylococcal Infections; Tobramycin; Vancomycin | 1982 |
Comparative penetration of six antibiotics into the cerebrospinal fluid of rabbits with experimental staphylococcal meningitis.
Topics: Animals; Anti-Bacterial Agents; Cephalothin; Cephradine; Disease Models, Animal; Leukocyte Count; Male; Meningitis; Methicillin; Nafcillin; Oxacillin; Rabbits; Staphylococcal Infections; Vancomycin | 1980 |
Oxacillin-induced pseudomembranous colitis.
Topics: Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Oxacillin; Staphylococcal Infections; Vancomycin | 1980 |
In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus.
Topics: Ciprofloxacin; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Fusidic Acid; Gentamicins; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Rifampin; Staphylococcus aureus; Vancomycin | 1994 |
Comparative efficacies of imipenem, oxacillin and vancomycin for therapy of chronic foreign body infection due to methicillin-susceptible and -resistant Staphylococcus aureus.
Topics: Animals; Chronic Disease; Diffusion Chambers, Culture; Dose-Response Relationship, Drug; Foreign-Body Reaction; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Polytetrafluoroethylene; Prostheses and Implants; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1994 |
Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureus.
Topics: Animals; Aortic Valve; Endocarditis, Bacterial; Female; Microbial Sensitivity Tests; Minocycline; Oxacillin; Penicillin Resistance; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tissue Distribution; Vancomycin | 1994 |
Susceptibility of Staphylococcus aureus growing on fibronectin-coated surfaces to bactericidal antibiotics.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Fibronectins; Fleroxacin; Methylmethacrylates; Microbial Sensitivity Tests; Oxacillin; Staphylococcus aureus; Vancomycin | 1993 |
In vitro activities of ramoplanin, selected glycopeptides, fluoroquinolones, and other antibiotics against clinical bloodstream isolates of gram-positive cocci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Depsipeptides; Drug Resistance, Microbial; Fluoroquinolones; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Oxacillin; Peptides, Cyclic; Teicoplanin; Vancomycin | 1993 |
Tolerance of Staphylococcus epidermidis grown from indwelling vascular catheters to antimicrobial agents.
Topics: Anti-Bacterial Agents; Biofilms; Catheters, Indwelling; Drug Resistance, Microbial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Ofloxacin; Oxacillin; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1995 |
In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Bacteremia; Catheterization, Central Venous; Cefamandole; Cephalosporins; Ciprofloxacin; Clindamycin; Daptomycin; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Neoplasms; Novobiocin; Oxacillin; Penicillins; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Vancomycin; Virginiamycin | 1996 |
Increased oxacillin activity associated with glycopeptides in coagulase-negative staphylococci.
Topics: Anti-Bacterial Agents; Coagulase; Drug Resistance, Microbial; Drug Resistance, Multiple; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Penicillins; Staphylococcus; Vancomycin | 1998 |
[Epidural and intramedullary abscess of acute onset].
Topics: 4-Quinolones; Abscess; Anti-Infective Agents; Drug Therapy, Combination; Epidural Space; Fluoroquinolones; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Oxacillin; Pefloxacin; Quinolones; Spinal Cord Diseases; Vancomycin | 1998 |
Molecular characterization of epidemic multiresistant Staphylococcus haemolyticus isolates.
Topics: Ampicillin; Anti-Bacterial Agents; Cefazolin; Cefmetazole; Cross Infection; DNA Restriction Enzymes; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Gentamicins; Hospital Bed Capacity, 500 and over; Humans; Imipenem; Infant, Newborn; Microbial Sensitivity Tests; Neonatal Nursing; Nursing Staff, Hospital; Ofloxacin; Oxacillin; Phylogeny; Staphylococcal Infections; Staphylococcus; Tobramycin; Vancomycin | 1998 |
Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; Blood; Child, Preschool; Coagulase; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Oxacillin; Penicillins; Staphylococcal Infections; Staphylococcus; Teicoplanin; Vancomycin | 1999 |
Cell wall-affecting antibiotics induce expression of a novel gene, drp35, in Staphylococcus aureus.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacitracin; Bacterial Proteins; Carrier Proteins; Cell Wall; Cloning, Molecular; Fosfomycin; Gene Expression Regulation, Bacterial; Genes, Bacterial; Hexosyltransferases; Hydrolases; Methicillin Resistance; Molecular Sequence Data; Multienzyme Complexes; Muramoylpentapeptide Carboxypeptidase; Oxacillin; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Staphylococcus aureus; Transcription, Genetic; Vancomycin | 1999 |
The effects of vancomycin and beta-lactam antibiotics on vancomycin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Ceftizoxime; Drug Therapy, Combination; Humans; Oxacillin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 1999 |
MICs of mutacin B-Ny266, nisin A, vancomycin, and oxacillin against bacterial pathogens.
Topics: Anti-Bacterial Agents; Bacteria; Bacteriocins; Drug Resistance, Microbial; Microbial Sensitivity Tests; Nisin; Oxacillin; Vancomycin | 2000 |
Vancomycin and oxacillin synergy for methicillin-resistant staphylococci.
Topics: Drug Synergism; Drug Therapy, Combination; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Staphylococcus; Time Factors; Vancomycin | 2000 |
Adults with meningitis caused by oxacillin-resistant Staphylococcus aureus.
Topics: Adolescent; Adult; Aged; Ampicillin; Drug Resistance, Microbial; Drug Resistance, Multiple; Female; Hospitals; Humans; Male; Meningitis; Microbial Sensitivity Tests; Middle Aged; Oxacillin; Penicillin G; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Vancomycin | 2000 |
Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of project ICARE laboratories.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Erythromycin; Humans; Imipenem; Laboratories, Hospital; Meropenem; Ofloxacin; Oxacillin; Penicillins; Pseudomonas aeruginosa; Reproducibility of Results; Serratia marcescens; Staphylococcus aureus; Streptococcus pneumoniae; Thienamycins; Vancomycin | 2000 |
Fulminant late-onset sepsis in a neonatal intensive care unit, 1988-1997, and the impact of avoiding empiric vancomycin therapy.
Topics: Abnormalities, Multiple; Bacterial Infections; Candidiasis; Comorbidity; Cross Infection; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Meningitis; North Carolina; Oxacillin; Retrospective Studies; Sepsis; Staphylococcal Infections; Vancomycin; Virginia | 2000 |
[Cloxacilin and vancomycin bacterial action against oxalicin-susceptible Staphylococcus aureus].
Topics: Anti-Bacterial Agents; Cloxacillin; Oxacillin; Penicillin Resistance; Penicillins; Staphylococcus aureus; Vancomycin | 2001 |
Cloning and sequencing of the gene, fmtC, which affects oxacillin resistance in methicillin-resistant Staphylococcus aureus.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacitracin; Base Sequence; Fosfomycin; Genes, Bacterial; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Sequence Data; Mutagenesis, Insertional; Open Reading Frames; Oxacillin; Penicillins; Staphylococcus aureus; Vancomycin | 2001 |
Methicillin-resistant Staphylococcus aureus: comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carrier Proteins; Hexosyltransferases; Humans; Latex Fixation Tests; Methicillin Resistance; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Oxacillin; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Sensitivity and Specificity; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2001 |
Conversion of oxacillin-resistant staphylococci from heterotypic to homotypic resistance expression.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carrier Proteins; Drug Resistance; Hexosyltransferases; Macrolides; Muramoylpentapeptide Carboxypeptidase; Oxacillin; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Phenotype; Staphylococcus; Vancomycin | 2002 |
A microdilution plating method for population analysis of antibiotic-resistant staphylococci.
Topics: Anti-Bacterial Agents; Colony Count, Microbial; Culture Media; Drug Resistance; Microbial Sensitivity Tests; Oxacillin; Penicillins; Population; Staphylococcus aureus; Vancomycin | 2001 |
Application of the IDSA guidelines for the use of antimicrobial agents in neutropenic patients: impact on reducing the use of glycopeptides.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Brazil; Cefepime; Ceftazidime; Cephalosporins; Child; Drug Therapy, Combination; Female; Fever; Hospitals, Teaching; Humans; Male; Middle Aged; Neutropenia; Oxacillin; Practice Guidelines as Topic; Teicoplanin; Treatment Outcome; Vancomycin | 2001 |
Glycopeptide susceptibility profiles of nosocomial multiresistant Staphylococcus haemolyticus isolates.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections; Staphylococcus; Teicoplanin; Vancomycin; Vancomycin Resistance | 2001 |
Vancomycin susceptibility of oxacillin-resistant Staphylococcus aureus isolates causing nosocomial bloodstream infections.
Topics: Anti-Bacterial Agents; Bacteremia; Cross Infection; Drug Resistance, Bacterial; Hospitalization; Humans; Microbial Sensitivity Tests; Oxacillin; Penicillins; Population Surveillance; Staphylococcal Infections; Staphylococcus aureus; United States; Vancomycin | 2002 |
Practical therapeutic application of the oxoid PBP2' latex agglutination test for the rapid identification of methicillin-resistant Staphylococcus aureus in blood cultures.
Topics: Humans; Latex Fixation Tests; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Penicillins; Staphylococcus aureus; Vancomycin | 2002 |
Pine oil cleaner-resistant Staphylococcus aureus: reduced susceptibility to vancomycin and oxacillin and involvement of SigB.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Oxacillin; Pinus; Plant Oils; Sigma Factor; Staphylococcus aureus; Vancomycin | 2002 |
Disseminated oxacillin-resistant Staphylococcus aureus infection responsive to vancomycin and quinupristin-dalfopristin combination therapy.
Topics: Aged; Drug Therapy, Combination; Female; Humans; Oxacillin; Penicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin | 2003 |
Comparative in vitro activity of quinupristin/dalfopristin and seven other antimicrobials against methicillin-susceptible and methicillin-resistant nosocomial Staphylococcus aureus bloodstream isolates.
Topics: Anti-Bacterial Agents; Bacteremia; Clindamycin; Cross Infection; Erythromycin; Gentamicins; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Virginiamycin | 2002 |
Transcriptional induction of the penicillin-binding protein 2 gene in Staphylococcus aureus by cell wall-active antibiotics oxacillin and vancomycin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Blotting, Northern; Blotting, Western; Carrier Proteins; Cell Wall; DNA Probes; DNA, Bacterial; Hexosyltransferases; Molecular Sequence Data; Multienzyme Complexes; Muramoylpentapeptide Carboxypeptidase; Oxacillin; Penicillin Resistance; Penicillin-Binding Proteins; Penicillins; Peptides, Cyclic; Peptidyl Transferases; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus aureus; Transcription, Genetic; Vancomycin; Vancomycin Resistance | 2003 |
Endocarditis due to glycopeptide-intermediate Staphylococcus aureus: case report and strain characterization.
Topics: Drug Resistance, Multiple, Bacterial; Endocarditis; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Oxacillin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2003 |
Efficacy of vancomycin-beta-lactam combinations against heterogeneously vancomycin-resistant Staphylococcus aureus (hetero-VRSA).
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cefotaxime; Drug Synergism; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Oxacillin; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2003 |
Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacitracin; Bacterial Proteins; beta-Lactam Resistance; Ceftizoxime; Cell Wall; DNA-Binding Proteins; Drug Resistance, Multiple, Bacterial; Fosfomycin; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Oxacillin; Receptors, Cell Surface; RNA, Bacterial; RNA, Messenger; Staphylococcus aureus; Teicoplanin; Transcription, Genetic; Vancomycin | 2003 |
Clinical impact of a PCR assay for identification of Staphylococcus aureus and determination of methicillin resistance directly from blood cultures.
Topics: Blood; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Polymerase Chain Reaction; Reproducibility of Results; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2003 |
Investigation of antibiotic and antibacterial agent cross-resistance in target bacteria from homes of antibacterial product users and nonusers.
Topics: Ampicillin; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Bacterial; Enterococcus; Environment; Gram-Negative Bacteria; Gram-Positive Bacteria; Household Products; Microbial Sensitivity Tests; Oxacillin; Plant Oils; Random Allocation; Soil Microbiology; Triclosan; Vancomycin; Xylenes | 2003 |
PRODUCTION OF A POLYSACCHARIDE BY STAPHYLOCOCCUS AUREUS. II. EFFECT OF TEMPERATURE AND ANTIBIOTICS.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antimetabolites; Carbohydrate Metabolism; Erythromycin; Hyaluronoglucosaminidase; Methicillin; Muramidase; Oxacillin; Polysaccharides; Polysaccharides, Bacterial; Research; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Temperature; Trypsin; Vancomycin | 1963 |
[RAPID DETERMINATION OF THE SENSITIVITY OF BACTERIA TO ANTIBIOTICS].
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Colistin; Drug Resistance; Drug Resistance, Microbial; Erythromycin; Escherichia coli; Kanamycin; Methicillin; Neomycin; Oleandomycin; Oxacillin; Paromomycin; Penicillin G; Polymyxins; Research; Rifamycins; Staphylococcus; Streptomycin; Tetracycline; Tetrazolium Salts; Vancomycin | 1963 |
TREATMENT OF BACTERIAL ENDOPHTHALMITIS FOLLOWING CATARACT EXTRACTION.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anti-Bacterial Agents; Cataract Extraction; Chloramphenicol; Endophthalmitis; Methicillin; Novobiocin; Oxacillin; Postoperative Complications; Proteus Infections; Pseudomonas Infections; Staphylococcal Infections; Streptomycin; Tetracycline; Toxicology; Vancomycin | 1964 |
ENDOCARDITIS.
Topics: Diagnosis; Endocarditis; Endocarditis, Bacterial; Endocarditis, Subacute Bacterial; Heart Failure; Humans; Intracranial Embolism; Intracranial Embolism and Thrombosis; Methicillin; Mortality; Oxacillin; Penicillins; Ristocetin; Streptomycin; Vancomycin | 1964 |
[PRESENT STATUS OF THE TREATMENT OF STAPHYLOCOCCAL DISEASES].
Topics: Anti-Bacterial Agents; Cross Infection; Drug Therapy; Humans; Methicillin; Oxacillin; Penicillin G; Penicillins; Probenecid; Rifamycins; Staphylococcal Infections; Vancomycin | 1965 |
Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces.
Topics: Anti-Bacterial Agents; Biofilms; Lysostaphin; Methicillin Resistance; Microscopy, Electron, Scanning; Oxacillin; Penicillins; Staphylococcus aureus; Staphylococcus epidermidis; Surface Properties; Vancomycin | 2003 |
High level oxacillin and vancomycin resistance and altered cell wall composition in Staphylococcus aureus carrying the staphylococcal mecA and the enterococcal vanA gene complex.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Cell Wall; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Resistance; Drug Resistance, Microbial; Enterococcus; Lactams; Mass Spectrometry; Models, Chemical; Operon; Oxacillin; Peptides; Peptidoglycan; Staphylococcus aureus; Time Factors; Vancomycin | 2004 |
Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; Blotting, Southern; Carbon-Oxygen Ligases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Ofloxacin; Oxacillin; Penicillins; Pennsylvania; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2004 |
[Bacterial colonization of chronic wounds. Studies on outpatients in a university dermatology clinic with special consideration of ORSA].
Topics: Aged; Aged, 80 and over; Bacteriological Techniques; Chronic Disease; Clindamycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Foot Ulcer; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Oxacillin; Penicillin Resistance; Pressure Ulcer; Radiodermatitis; Skin Diseases, Bacterial; Skin Ulcer; Staphylococcal Skin Infections; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Vancomycin Resistance; Varicose Ulcer; Wound Infection | 2004 |
Vancomycin-induced deletion of the methicillin resistance gene mecA in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Autolysis; Bacterial Proteins; Cell Wall; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Deletion; Lysostaphin; Methicillin Resistance; Microbial Sensitivity Tests; Microscopy, Electron; Oxacillin; Penicillin-Binding Proteins; Penicillins; Phenotype; Staphylococcus aureus; Trans-Activators; Vancomycin | 2004 |
Antimicrobial-resistance and enterotoxin-encoding genes among staphylococci isolated from expressed human breast milk.
Topics: Anti-Bacterial Agents; Clindamycin; DNA, Bacterial; Drug Resistance, Bacterial; Enterotoxins; Erythromycin; Female; Genes, Bacterial; Gentamicins; Humans; Microbial Sensitivity Tests; Milk, Human; Oxacillin; Penicillins; Polymerase Chain Reaction; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Staphylococcus haemolyticus; Superantigens; Vancomycin | 2004 |
In vitro activity of oxacillin, vancomycin and teicoplanin against staphylococci isolated from patients on surgical and coronary intensive care units.
Topics: Anti-Bacterial Agents; Cardiology; Coagulase; Drug Resistance, Bacterial; General Surgery; Humans; Intensive Care Units; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Teicoplanin; Vancomycin | 2004 |
Cervical spondylodiscitis from an ingested pin: a case report.
Topics: Accidents; Adolescent; Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxis; Bone Plates; Ceftriaxone; Cervical Vertebrae; Clindamycin; Combined Modality Therapy; Deglutition Disorders; Discitis; Diskectomy; Emergencies; Equipment Contamination; Follow-Up Studies; Foreign Bodies; Humans; Laryngoscopy; Larynx; Male; Neck Pain; Oxacillin; Paresthesia; Penicillanic Acid; Pharynx; Piperacillin; Piperacillin, Tazobactam Drug Combination; Radiography; Recurrence; Retropharyngeal Abscess; Spinal Fusion; Vancomycin; Wounds, Penetrating | 2005 |
Coagulase-negative staphylococcal meningitis in adults: clinical characteristics and therapeutic outcomes.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Female; Humans; Linezolid; Male; Meningitis, Bacterial; Middle Aged; Oxacillin; Oxazolidinones; Penicillin Resistance; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2005 |
An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Clindamycin; Community-Acquired Infections; Erythromycin; Female; Humans; Kentucky; Levofloxacin; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Oxacillin; Rifampin; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Tetracycline; Trimethoprim; Vancomycin | 2005 |
Evaluation of the efficacy and safety of outpatient parenteral antimicrobial therapy for infections with methicillin-sensitive Staphylococcus aureus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Child; Child, Preschool; Clindamycin; Drug Monitoring; Female; Home Infusion Therapy; Humans; Infant; Infusions, Parenteral; Male; Middle Aged; Nafcillin; Oxacillin; Retrospective Studies; Streptococcal Infections; Treatment Outcome; Vancomycin | 2005 |
Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides.
Topics: Anti-Bacterial Agents; APACHE; Cohort Studies; Drug Resistance, Bacterial; Female; Glycopeptides; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Oxacillin; Pneumonia, Staphylococcal; Retrospective Studies; Staphylococcus aureus; Teicoplanin; Vancomycin; Ventilators, Mechanical | 2005 |
Evaluation of high-dose daptomycin for therapy of experimental Staphylococcus aureus foreign body infection.
Topics: Animals; Anti-Bacterial Agents; Daptomycin; Foreign Bodies; Microbial Sensitivity Tests; Oxacillin; Rats; Staphylococcal Infections; Vancomycin | 2006 |
Occurrence of methicillin-resistant Staphylococcus aureus strains from cattle and chicken, and analyses of their mecA, mecR1 and mecI genes.
Topics: Animals; Bacterial Proteins; Cattle; Cattle Diseases; Chickens; DNA Primers; Methicillin Resistance; Microbial Sensitivity Tests; Operator Regions, Genetic; Oxacillin; Penicillin-Binding Proteins; Point Mutation; Poultry Diseases; Promoter Regions, Genetic; Repressor Proteins; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus aureus; Swine; Swine Diseases; Vancomycin | 2006 |
Diminished macrophage inflammatory response to Staphylococcus aureus isolates exposed to daptomycin versus vancomycin or oxacillin.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cells, Cultured; Colony Count, Microbial; Daptomycin; Drug Interactions; Humans; Macrophages; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Nitric Oxide Synthase Type II; Oxacillin; Staphylococcus aureus; Tumor Necrosis Factor-alpha; Vancomycin | 2006 |
[Drug-resistance of staphylococcus aureus and detection of mecA gene in all strains isolated from children in Hangzhou].
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cefotaxime; Ceftriaxone; Child; Child, Preschool; China; Drug Resistance, Bacterial; Erythromycin; Humans; Latex Fixation Tests; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Penicillin-Binding Proteins; Penicillins; Polymerase Chain Reaction; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Endocarditis, Bacterial; Methicillin; Microbial Sensitivity Tests; Nafcillin; Oxacillin; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2006 |
Staphylococcus aureus biofilm as a target for single or repeated doses of oxacillin, vancomycin, linezolid and/or lysostaphin.
Topics: Acetamides; Anti-Bacterial Agents; Biofilms; Drug Therapy, Combination; Humans; Linezolid; Lysostaphin; Microbial Sensitivity Tests; Microscopy, Confocal; Oxacillin; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
[Catheter associated Staphylococcus sciuri sepsis in a patient with acute myeloid leukemia].
Topics: Anti-Bacterial Agents; Bacteremia; Catheters, Indwelling; Drug Resistance, Bacterial; Female; Humans; Leukemia, Myeloid, Acute; Meropenem; Middle Aged; Neutropenia; Oxacillin; Penicillin Resistance; Staphylococcal Infections; Staphylococcus; Thienamycins; Vancomycin | 2006 |
Activity of dalbavancin tested against Staphylococcus spp. and beta-hemolytic Streptococcus spp. isolated from 52 geographically diverse medical centers in the United States.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Oxacillin; Staphylococcus; Streptococcus; Teicoplanin; United States; Vancomycin | 2007 |
In vitro activity of antimicrobial agents against oxacillin resistant staphylococci with special reference to Staphylococcus haemolyticus.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; India; Linezolid; Microbial Sensitivity Tests; Oxacillin; Oxazolidinones; Staphylococcus; Staphylococcus haemolyticus; Teicoplanin; Vancomycin; Virginiamycin | 2007 |
High-level oxacillin and gentamycin resistance with reduced susceptibility to vancomycin in Staphylococcus aureus-carrying mecA and femA gene complex.
Topics: Bacterial Proteins; beta-Lactamases; Cell Wall; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Sequence Data; Oxacillin; Penicillin-Binding Proteins; Staphylococcus aureus; Vancomycin | 2007 |
Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Vancomycin | 2007 |
Zinc(II) coordination complexes as membrane-active fluorescent probes and antibiotics.
Topics: Anti-Bacterial Agents; Cations, Divalent; Cell Membrane; Drug Resistance, Bacterial; Fluorescent Dyes; Microscopy, Fluorescence; Organometallic Compounds; Oxacillin; Oxidation-Reduction; Phospholipids; Solutions; Staining and Labeling; Staphylococcus aureus; Vancomycin; Water; Zinc | 2008 |
Variability in vancomycin use in newborn intensive care units determined from data in an electronic medical record.
Topics: Anti-Bacterial Agents; Cross Infection; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Intensive Care Units, Neonatal; Male; Medical Records Systems, Computerized; Nafcillin; Oxacillin; Vancomycin | 2008 |
In vitro and in vivo evaluations of oxacillin efficiency against mecA-positive oxacillin-susceptible Staphylococcus aureus.
Topics: Animals; Bacterial Proteins; Dicloxacillin; Genes, Bacterial; Humans; Male; Methicillin Resistance; Mice; Oxacillin; Penicillin Resistance; Penicillin-Binding Proteins; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
Frequency of mecA gene and borderline oxacillin resistant Staphylococcus aureus in nosocomial acquired methicillin resistance Staphylococcus aureus infections.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cross Infection; Humans; Infectious Disease Transmission, Professional-to-Patient; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Penicillin-Binding Proteins; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
Role of mgrA and sarA in methicillin-resistant Staphylococcus aureus autolysis and resistance to cell wall-active antibiotics.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacteriolysis; Cell Wall; Community-Acquired Infections; Disease Models, Animal; Drug Resistance, Bacterial; Endocarditis, Bacterial; Gene Expression Regulation, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; N-Acetylmuramoyl-L-alanine Amidase; Oxacillin; Rabbits; Staphylococcal Infections; Trans-Activators; Vancomycin | 2009 |
Continuous-infusion oxacillin for the treatment of burn wound cellulitis.
Topics: Adult; Aged; Anti-Bacterial Agents; Burns; Cellulitis; Cohort Studies; Female; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Leukocytosis; Male; Middle Aged; Oxacillin; Retrospective Studies; Vancomycin; Young Adult | 2009 |
Increasing invasive disease due to penicillin resistant S. pneumoniae in India.
Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Drug Therapy, Combination; Humans; India; Male; Oxacillin; Penicillin Resistance; Streptococcal Infections; Streptococcus pneumoniae; Vancomycin | 2008 |
Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacteriolysis; Colony Count, Microbial; Daptomycin; Humans; Microbial Sensitivity Tests; Microbial Viability; Octoxynol; Oxacillin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Lack of bactericidal antagonism or synergism in vitro between oxacillin and vancomycin against methicillin-susceptible strains of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Drug Antagonism; Drug Synergism; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Vancomycin | 2010 |
Telavancin.
Topics: Adult; Aminoglycosides; Animals; Anti-Bacterial Agents; Cross Infection; Disease Models, Animal; Drug Administration Schedule; Drug Interactions; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacteria; Humans; Lipoglycopeptides; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Skin Diseases, Infectious; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2009 |
Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Base Sequence; Disease Models, Animal; DNA Primers; DNA, Viral; Drug Synergism; Female; Genes, Viral; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Microscopy, Electron, Transmission; Oxacillin; Protein Engineering; Recombinant Fusion Proteins; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus Phages; Vancomycin; Viral Proteins | 2010 |
Staphylococcal strains adapted to epigallocathechin gallate (EGCG) show reduced susceptibility to vancomycin, oxacillin and ampicillin, increased heat tolerance, and altered cell morphology.
Topics: Adaptation, Physiological; Ampicillin; Anti-Bacterial Agents; Catechin; Cell Wall; Drug Resistance, Multiple, Bacterial; Hot Temperature; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Oxacillin; Staphylococcus aureus; Vancomycin | 2010 |
Impregnation of bone chips with antibiotics and storage of antibiotics at different temperatures: an in vitro study.
Topics: Acetamides; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bone Transplantation; Cefazolin; Clindamycin; Dose-Response Relationship, Drug; Drug Compounding; Drug Stability; Drug Storage; Humans; Linezolid; Microbial Sensitivity Tests; Oxacillin; Oxazolidinones; Prosthesis-Related Infections; Staphylococcus epidermidis; Surgical Wound Infection; Temperature; Transplantation, Homologous; Vancomycin | 2010 |
Diminished in vitro antibacterial activity of oxacillin against clinical isolates of borderline oxacillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Daptomycin; Drug Resistance, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Oxacillin; Oxazolidinones; Penicillin Resistance; Penicillin-Binding Proteins; Plasmids; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2010 |
Effect of sub-lethal doses of vancomycin and oxacillin on biofilm formation by vancomycin intermediate resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Biofilms; Humans; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Oxacillin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2011 |
Susceptibility patterns of coagulase-negative staphylococci to several newer antimicrobial agents in comparison with vancomycin and oxacillin.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; DNA, Ribosomal; Linezolid; Lipoglycopeptides; Microbial Sensitivity Tests; Micrococcal Nuclease; Minocycline; Oxacillin; Oxazolidinones; Penicillin-Binding Proteins; Polymerase Chain Reaction; Staphylococcus; Tigecycline; Vancomycin | 2011 |
In vitro potentiation of ampicillin, oxacillin, norfloxacin, ciprofloxacin, and vancomycin by sanguinarine against methicillin-resistant Staphylococcus aureus.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Load; Benzophenanthridines; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Isoquinolines; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Norfloxacin; Oxacillin; Species Specificity; Vancomycin | 2011 |
Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.
Topics: Acetamides; Bacterial Toxins; Ceftaroline; Cephalosporins; Clindamycin; Daptomycin; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Exotoxins; Leukocidins; Levofloxacin; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Ofloxacin; Oxacillin; Oxazolidinones; Polymerase Chain Reaction; Staphylococcus aureus; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Vancomycin | 2011 |
In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates.
Topics: alpha-Defensins; Antimicrobial Cationic Peptides; beta-Thromboglobulin; Daptomycin; Genotype; Gentamicins; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Polymyxin B; Vancomycin | 2011 |
[Antibiotic resistance dynamics and isolation rate of staphylococci and enterococci from patients of reconstructive surgery units].
Topics: Acetamides; Amoxicillin; Anti-Bacterial Agents; Cefoxitin; Cross Infection; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Fusidic Acid; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Moscow; Oxacillin; Oxazolidinones; Rifampin; Surgery, Plastic; Vancomycin | 2011 |
Peritonitis in recent years: clinical findings and predictors of treatment response of 170 episodes at a single Brazilian center.
Topics: Age Factors; Aged; Amikacin; Anti-Bacterial Agents; Brazil; Cefazolin; Ceftazidime; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Enterococcus; Female; Humans; Male; Middle Aged; Multivariate Analysis; Oxacillin; Peritoneal Dialysis; Peritonitis; Recurrence; Staphylococcal Infections; Streptococcal Infections; Survival Analysis; Treatment Outcome; Vancomycin | 2012 |
Activity of oxacillin versus that of vancomycin against oxacillin-susceptible mecA-positive Staphylococcus aureus clinical isolates evaluated by population analyses, time-kill assays, and a murine thigh infection model.
Topics: Animals; Anti-Bacterial Agents; Dicloxacillin; Female; Mice; Mice, Inbred BALB C; Oxacillin; Staphylococcal Infections; Staphylococcus aureus; Thigh; Vancomycin | 2012 |
Interplay of antibiotics and bacterial inoculum on suture-associated biofilms.
Topics: Ampicillin; Anti-Bacterial Agents; Biofilms; Microbial Sensitivity Tests; Microscopy, Confocal; Oxacillin; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Sutures; Vancomycin | 2012 |
Incidence and characterization of Staphylococcus aureus in fishery products marketed in Galicia (Northwest Spain).
Topics: Anti-Bacterial Agents; Clindamycin; Drug Resistance, Microbial; Erythromycin; Incidence; Microbial Sensitivity Tests; Oxacillin; Random Amplified Polymorphic DNA Technique; Seafood; Spain; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2012 |
Synergy of flavone with vancomycin and oxacillin against vancomycin-intermediate Staphyloccus aureus.
Topics: Anti-Bacterial Agents; Drug Combinations; Drug Synergism; Flavonoids; Microbial Sensitivity Tests; Oxacillin; Staphylococcus aureus; Vancomycin | 2012 |
Superparamagnetic iron oxide nanoparticles (SPION) for the treatment of antibiotic-resistant biofilms.
Topics: Anti-Bacterial Agents; Biofilms; Chelating Agents; Ferric Compounds; Ferrous Compounds; Gentamicins; Microbial Sensitivity Tests; Nanoparticles; Oxacillin; Staphylococcus aureus; Succimer; Vancomycin | 2012 |
Antibacterial activity of joint fluid in cemented total-knee arthroplasty: an in vivo comparative study of polymethylmethacrylate with and without antibiotic loading.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthroplasty, Replacement, Knee; Cefazolin; Cementation; Chromatography, High Pressure Liquid; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxacillin; Polymethyl Methacrylate; Staphylococcal Infections; Synovial Fluid; Vancomycin | 2012 |
In vitro synergy of oxacillin and gentamicin against coagulase-negative staphylococci from blood cultures of neonates with late-onset sepsis.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Coagulase; Culture Media; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Humans; Infant, Newborn; Microbial Sensitivity Tests; Oxacillin; Sepsis; Staphylococcal Infections; Staphylococcus; Vancomycin | 2013 |
Novel combinations of vancomycin plus ceftaroline or oxacillin against methicillin-resistant vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA.
Topics: Anti-Bacterial Agents; Boron Compounds; Ceftaroline; Cell Wall; Cephalosporins; Drug Combinations; Drug Synergism; Fluorescent Dyes; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Vancomycin; Vancomycin Resistance | 2013 |
Antimicrobial/anti-biofilm activity of expired blood platelets and their released products.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Thromboglobulin; Biofilms; Blood Platelets; Endocarditis, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Oxacillin; Oxazolidinones; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Vancomycin | 2013 |
Methicillin-resistant coagulase-negative staphylococci (MRCoNS) by disk diffusion method.
Topics: Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Ciprofloxacin; Coagulase; Drug Resistance, Multiple, Bacterial; Exudates and Transudates; Gentamicins; Humans; Imipenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections; Suppuration; Surgical Wound Infection; Vancomycin | 2013 |
Population structure and characterisation of Staphylococcus aureus from bacteraemia at multiple hospitals in China: association between antimicrobial resistance, toxin genes and genotypes.
Topics: Bacteremia; Bacterial Toxins; Bacterial Typing Techniques; China; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterotoxins; Genotype; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Multilocus Sequence Typing; Oxacillin; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2013 |
Multidrug-resistant bacterial isolates in infected wounds at Jimma University Specialized Hospital, Ethiopia.
Topics: Anti-Bacterial Agents; Bacteria; Citrobacter; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethiopia; Hospitals, University; Humans; Klebsiella; Methicillin; Microbial Sensitivity Tests; Oxacillin; Proteus; Providencia; Staphylococcus; Vancomycin; Wound Infection | 2013 |
Staphylococcus aureus keratitis: a review of hospital cases.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Clindamycin; Erythromycin; Female; Humans; Infant; Keratitis; Male; Methicillin; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxacillin; Prognosis; Staphylococcal Infections; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Visual Acuity | 2013 |
Evaluation of vancomycin in combination with piperacillin-tazobactam or oxacillin against clinical methicillin-resistant Staphylococcus aureus Isolates and vancomycin-intermediate S. aureus isolates in vitro.
Topics: Anti-Bacterial Agents; Drug Combinations; Drug Synergism; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2014 |
Comparison of Sensititre microdilution method to other standard methods for susceptibility testing of coagulase-negative staphylococci from paediatric blood cultures.
Topics: Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clindamycin; Daptomycin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Oxacillin; Staphylococcus epidermidis; Staphylococcus hominis; Tetracycline; Vancomycin | 2014 |
Peritoneal dialysis-related peritonitis due to coagulase-negative Staphylococcus: a review of 115 cases in a Brazilian center.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Brazil; Coagulase; Female; Humans; Incidence; Male; Middle Aged; Oxacillin; Penicillin Resistance; Peritoneal Dialysis; Peritonitis; Staphylococcal Infections; Staphylococcus; Vancomycin | 2014 |
Comparison of M.I.C.E. and Etest with CLSI agar dilution for antimicrobial susceptibility testing against oxacillin-resistant Staphylococcus spp.
Topics: Acetamides; Agar; Anti-Infective Agents; Drug Resistance, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Oxacillin; Oxazolidinones; Regression Analysis; Reproducibility of Results; Staphylococcus; Teicoplanin; Vancomycin | 2014 |
[Estimation of MRSA susceptibility to oxacillin, cefoxitine, vancomycin and daptomycin].
Topics: Anti-Bacterial Agents; Cefoxitin; Daptomycin; Dose-Response Relationship, Drug; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Vancomycin | 2013 |
The occurrence and dissemination of methicillin and vancomycin-resistant Staphylococcus in samples from patients and health professionals of a university hospital in Recife, State of Pernambuco, Brazil.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Brazil; Cross Infection; Female; Health Personnel; Hospitals, University; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Nasal Cavity; Oxacillin; Penicillin-Binding Proteins; Polymerase Chain Reaction; Ribotyping; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2014 |
Inefficacy of vancomycin and teicoplanin in eradicating and killing Staphylococcus epidermidis biofilms in vitro.
Topics: Anti-Bacterial Agents; Biofilms; Drug Interactions; Gentamicins; Humans; Microbial Viability; Oxacillin; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 2015 |
Clinical and microbiological characteristics of six Staphylococcus pettenkoferi isolates from blood samples.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; DNA, Bacterial; Drug Resistance, Bacterial; Female; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxacillin; Phenotype; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus; Vancomycin | 2015 |
Antibacterial Characterization of Novel Synthetic Thiazole Compounds against Methicillin-Resistant Staphylococcus pseudintermedius.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Dog Diseases; Dogs; Lysostaphin; Methicillin; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Oxacillin; Rifampin; Staphylococcal Infections; Staphylococcus; Thiazoles; Vancomycin | 2015 |
Modulation of inflammatory mediators during treatment of cellulitis with daptomycin or vancomycin/oxacillin.
Topics: Adolescent; Adult; Aged; Animals; Cellulitis; Cytokines; Daptomycin; Humans; Middle Aged; Oxacillin; Prospective Studies; Time Factors; Treatment Outcome; Vancomycin; Young Adult | 2015 |
Bioaerosol exposure to personnel in a clinical environment absent patients.
Topics: Air Microbiology; Air Pollutants, Occupational; Drug Resistance, Bacterial; Florida; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospitals, Community; Housekeeping, Hospital; Humans; Infectious Disease Transmission, Patient-to-Professional; Occupational Exposure; Oxacillin; Respiratory Protective Devices; Vancomycin | 2016 |
Susceptibility Profile of Staphylococcus epidermidis and Staphylococcus haemolyticus Isolated from Blood Cultures to Vancomycin and Novel Antimicrobial Drugs over a Period of 12 Years.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Blood Culture; Brazil; Daptomycin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Hospitals, Teaching; Humans; Linezolid; Minocycline; Mutation; Oxacillin; Prevalence; Staphylococcal Infections; Staphylococcus epidermidis; Staphylococcus haemolyticus; Tigecycline; Vancomycin; Virginiamycin | 2016 |
[Comparison of tigecycline and vancomycin activities in an in vitro biofilm model generated with methicillin-resistant Staphylococcus aureus].
Topics: Anti-Bacterial Agents; Biofilms; Catheter-Related Infections; Coloring Agents; Congo Red; Disk Diffusion Antimicrobial Tests; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxacillin; Staphylococcal Infections; Tigecycline; Vancomycin | 2015 |
Antibiotic Susceptibility of Biofilm Cells and Molecular Characterisation of Staphylococcus hominis Isolates from Blood.
Topics: Amidohydrolases; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Biofilms; Cefoxitin; Chromosomes, Bacterial; Ciprofloxacin; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Humans; Methicillin; Microbial Sensitivity Tests; Operon; Oxacillin; Penicillin-Binding Proteins; Phylogeny; Plankton; Staphylococcal Infections; Staphylococcus hominis; Vancomycin | 2015 |
Phenotypic and Molecular Aspects of Staphylococcus spp. Isolated from Hospitalized Patients and Beef in the Brazilian Amazon.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Brazil; Cattle; Coagulase; Foodborne Diseases; Humans; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Red Meat; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Vancomycin | 2016 |
Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clindamycin; Dibekacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fusidic Acid; Gentamicins; Humans; Infant; Infant, Newborn; Ketolides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mupirocin; Oxacillin; Republic of Korea; Retrospective Studies; Rifampin; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Tetracycline; Vancomycin; Virginiamycin; Young Adult | 2016 |
Synergistic effects of vancomycin and β-lactams against vancomycin highly resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Bombyx; Ceftriaxone; Disease Models, Animal; Drug Synergism; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2017 |
Sphygmomanometers and thermometers as potential fomites of Staphylococcus haemolyticus: biofilm formation in the presence of antibiotics.
Topics: Anti-Bacterial Agents; Biofilms; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Fomites; Humans; Microbial Sensitivity Tests; Oxacillin; Sphygmomanometers; Staphylococcal Infections; Staphylococcus haemolyticus; Thermometers; Vancomycin | 2017 |
Dalbavancin treatment of prosthetic knee infection due to oxacillin-resistant Staphylococcus epidermidis.
Topics: Anti-Bacterial Agents; Arthroplasty, Replacement, Knee; Device Removal; Drug Resistance, Multiple, Bacterial; Female; Gentamicins; Humans; Knee Prosthesis; Middle Aged; Oxacillin; Prosthesis-Related Infections; Renal Insufficiency, Chronic; Staphylococcal Infections; Staphylococcus epidermidis; Teicoplanin; Time Factors; Vancomycin | 2018 |
Semi-quantitative MALDI-TOF for antimicrobial susceptibility testing in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Oxacillin; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2017 |
Plectranthus amboinicus essential oil and carvacrol bioactive against planktonic and biofilm of oxacillin- and vancomycin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Biofilms; Cymenes; Drug Resistance, Bacterial; Humans; Monoterpenes; Oils, Volatile; Oxacillin; Plant Extracts; Plant Leaves; Plectranthus; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2017 |
Vancomycin heteroresistance in coagulase negative Staphylococcus blood stream infections from patients of intensive care units in Mansoura University Hospitals, Egypt.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Cefoxitin; Coagulase; Drug Resistance, Bacterial; Egypt; Female; Genes, Bacterial; Hospitals, University; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Oxacillin; Penicillin-Binding Proteins; Prospective Studies; Staphylococcal Infections; Staphylococcus; Vancomycin; Vancomycin Resistance | 2017 |
A Retrospective Analysis of Treatment and Clinical Outcomes among Patients with Methicillin-Susceptible Staphylococcus aureus Bloodstream Isolates Possessing Detectable
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Cefoxitin; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Oxacillin; Penicillin-Binding Proteins; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2018 |
Cellular Pharmacokinetics and Intracellular Activity of Gepotidacin against Staphylococcus aureus Isolates with Different Resistance Phenotypes in Models of Cultured Phagocytic Cells.
Topics: Acenaphthenes; Anti-Bacterial Agents; Azithromycin; Cell Line; Daptomycin; Heterocyclic Compounds, 3-Ring; Humans; Linezolid; Macrolides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Oxacillin; Phagocytes; Staphylococcus aureus; THP-1 Cells; Vancomycin | 2018 |
Methicillin-sensible
Topics: Anti-Bacterial Agents; Diagnosis, Differential; Drug Therapy, Combination; Endocarditis, Bacterial; Heart Valve Prosthesis Implantation; Humans; Infant; Magnetic Resonance Imaging; Male; Meningitis, Bacterial; Methicillin-Resistant Staphylococcus aureus; Mitral Valve; Oxacillin; Staphylococcal Infections; Vancomycin | 2018 |
Effects of Microplate Type and Broth Additives on Microdilution MIC Susceptibility Assays.
Topics: Aminoglycosides; Anti-Bacterial Agents; Calcium; Ciprofloxacin; Colistin; Culture Media; Depsipeptides; Escherichia coli; Factor Analysis, Statistical; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Penicillin G; Plastics; Polymyxin B; Polysorbates; Rifampin; Teicoplanin; Trimethoprim; Vancomycin | 2019 |
Fatal sepsis caused by mecA-positive oxacillin-susceptible Staphylococcus aureus: First report in a tertiary hospital of southern Brazil.
Topics: Adult; Brazil; Fatal Outcome; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Oxacillin; Sepsis; Staphylococcal Infections; Tertiary Care Centers; Vancomycin | 2019 |
Nationwide Organism Susceptibility Patterns to Common Preoperative Prophylactic Antibiotics: What Are We Covering?
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Clindamycin; Data Collection; Humans; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; United States; Vancomycin | 2019 |
[The Epidemiological Profile of the Isolation of 'Problem' Microorganisms].
Topics: Bacterial Infections; Drug Resistance, Bacterial; Enterococcus; Female; Humans; Male; Oxacillin; Pseudomonas; Staphylococcus aureus; Streptococcus pneumoniae; Vancomycin | 2019 |
Surgical treatment of necrotizing pneumonia in children: a 10-year assessment.
Topics: Anti-Bacterial Agents; Ceftriaxone; Child, Preschool; Community-Acquired Infections; Cross-Sectional Studies; Drainage; Female; Humans; Infant; Length of Stay; Male; Medical Records; Oxacillin; Pneumonia, Necrotizing; Postoperative Complications; Retrospective Studies; Statistics, Nonparametric; Time Factors; Treatment Outcome; Vancomycin | 2020 |
Evaluation of fosfomycin combined with vancomycin against vancomycin-resistant coagulase negative staphylococci.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Coagulase; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fosfomycin; Genotype; Humans; Oxacillin; Phenotype; Vancomycin; Vancomycin Resistance | 2020 |
Antibacterial activity of Xenorhabdus and Photorhabdus isolated from entomopathogenic nematodes against antibiotic-resistant bacteria.
Topics: Animals; Anti-Bacterial Agents; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nematoda; Oxacillin; Photorhabdus; Phylogeny; Soil; Vancomycin; Xenorhabdus | 2020 |
Pet dogs as reservoir of oxacillin and vancomycin-resistant Staphylococcus spp.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Dog Diseases; Dogs; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections; Staphylococcus; Vancomycin | 2022 |
Arene-Ruthenium(II) Complexes with Carbothiamidopyrazoles as a Potential Alternative for Antibiotic Resistance in Human.
Topics: Anti-Bacterial Agents; Antioxidants; Cell Survival; Cells, Cultured; Drug Resistance, Microbial; Drug Synergism; Fibroblasts; Foreskin; Free Radical Scavengers; Humans; Hydrocarbons, Aromatic; Male; Oxacillin; Pyrazoles; Ruthenium Compounds; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 2022 |
Occurrence and Distribution of Antibiotic-Resistant Staphylococcus aureus in a Brazilian Pork Production Chain.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Brazil; Cefoxitin; Coagulase; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Pork Meat; Red Meat; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Swine; Vancomycin | 2022 |
Unravelling the physiological roles of mazEF toxin-antitoxin system on clinical MRSA strain by CRISPR RNA-guided cytidine deaminase.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Cytidine Deaminase; Daptomycin; Methicillin-Resistant Staphylococcus aureus; Mice; Oxacillin; RNA; Toxin-Antitoxin Systems; Vancomycin | 2022 |
Adaptive laboratory evolution and independent component analysis disentangle complex vancomycin adaptation trajectories.
Topics: Anti-Bacterial Agents; Evolution, Molecular; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance; Virulence | 2022 |
Methicillin- and Vancomycin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci Isolated from Hospital Foods: Prevalence and Antimicrobial Resistance Patterns.
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Cefoxitin; Clindamycin; Drug Resistance, Bacterial; Gentamicins; Hospitals; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Prevalence; Staphylococcus aureus; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Vancomycin-Resistant Enterococci; Vancomycin-Resistant Staphylococcus aureus | 2022 |
Characterization of oxacillin-resistant Staphylococcus lugdunensis isolated from sterile body fluids in a medical center in Taiwan: A 12-year longitudinal epidemiological study.
Topics: Anti-Bacterial Agents; Body Fluids; Ciprofloxacin; Erythromycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections; Staphylococcus lugdunensis; Sulfamethoxazole; Taiwan; Teicoplanin; Trimethoprim; Vancomycin | 2023 |
Does every Staphylococcus aureus infection require anti-MRSA drugs? Three case reports of a Staphylococcus aureus infection.
Topics: Adult; Anti-Bacterial Agents; Female; Humans; Infant, Newborn; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Oxacillin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2023 |
Late-onset neonatal infections and bacterial multidrug resistance.
Topics: Anti-Bacterial Agents; Bacterial Infections; Communicable Diseases; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Infant, Newborn; Microbial Sensitivity Tests; Oxacillin; Vancomycin | 2023 |
New synergistic antibacterial mechanism of bulky mixed Ti/w hetero-polyoxometalates composed of multi lacunary Keggin structure with oxacillin against vancomycin intermediate-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Drug Synergism; Methicillin-Resistant Staphylococcus aureus; Oxacillin; Staphylococcus aureus; Titanium; Vancomycin | 2023 |